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ABSTRACT 
The myosm regulatory light chain (RLC) of type II fibres is 
phosphorylated by Ca2+ -calmodulin dependent myosin light chain kinase 
(skMLCK) during muscular activation. The purpose of this study was to explore 
the effect of skMLCK gene ablation on the fatigability of mouse skeletal muscles 
during repetitive stimulation. The absence of myosin RLC phosphorylation in 
skMLCK knockout muscles attenuated contractile performance without a 
significant metabolic cost. Twitch force was potentiated to a greater extent in 
wildtype muscles until peak force had diminished to ~60% of baseline (37.2 ± 
0.05% vs. 14.3 ± 0.02%). Despite no difference in peak force (Po) and shortening 
velocity (Vo), rate of force development (+dP/dt) and shortening-induced 
deactivation (SID) were almost two-fold greater in WT muscles. The present 
results demonstrate that myosin RLC phosphorylation may improve contractile 
performance during fatigue; providing a contractile advantage to working muscles 
and protecting against progressive fatigue. 
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GLOSSARY 
Gene Ablation/Knockout: the sequence of nucleotides that code for the expression of proteins and enzymes 
can be manipulated to produce a specific experimental model. In this case, 
myosin light chain kinase (skMLCK) is selectively removed to effectively 
eliminate its expression within skeletal muscle. 
Phosphorylation: Adenosine triphosphate (ATP) is hydrolyzed by skMLCK to produce one ADP and one 
inorganic phosphate (Pi) molecule. The inorganic phosphate is bound to a specific portion 
of the myosin neck domain, known as the regulatory light chain (RLC). This biochemical 
event changes the structure and function of the protein (myosin) that produces force in 
the muscle. 
Muscle History Dependence: the phenomenon that prior contractile activity can alter subsequent 
performance. 
Fatigue: the reversible declines in contractile and/or metabolic performance that arises from repeated 
contractile activity in skeletal muscle. 
Conditioning Stimulus: a brief period of muscle activation that augments subsequent contractile activity. 
Potentiation (Force): a greater contractile response following some type of conditioning stimulus. Also 
known as twitch force potentiation, Posttetanic Potentiation (PTP), Activity-
dependent Potentiation, Postactivation Potentiation (PAP). 
Force-pCa Relationship: using skinned-fibres, the force response of the contractile apparatus can be tested 
at various levels of activation by varying [Ca2+]. In this relationship, force 
increases sigmoidally with increasing [Ca2+]. The term pCa refers to the negative 
logarithm of calcium concentration (-log[Ca2+]). 
Ca2+ Sensitivity: any factor which alters the contractile response to a given [Ca2+] is understood to alter the 
affinity of the contractile apparatus to muscle activation. Greater Ca2+ sensitivity will 
result in a greater contractile response to a given [Ca2+], or similarly, could allow the 
maintenance of some steady work output at a lower [Ca2+]. 
Contractile Apparatus: The myofilament array, composed of proteins (actin and myosin) that interact to 
produce mechanical forces and structural proteins that anchor the various 
components longitudinally and transversely. These structures make up the 
functional contractile unit of skeletal muscle, known as the sarcomere. 
Contractile Performance: The force-producing response of the contractile apparatus, the direct result of 
actin-myosin interactions during muscle activation. This term includes force 
production, velocity of shortening, and rate of force development. 
Physiological: the specific environmental conditions and functions that theoretically exist in the body. 
Statistically Significant: a statistical probability that suggests how sure we can be that a given observation 
(within a sample) truly reflects the nature of the event or measurement in the 
popUlation. The confidence interval (alpha <0.05) used in the current project 
suggests that the statistically significant conclusions herein would be recapitulated 
95% of the time when re-sampled. It is a justifiable and economical way to infer a 
certain finding across a popUlation by studying only a small sample. 
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I. INTRODUCTION 
Performance of the contractile apparatus in fast-twitch (Type IIA, IIX, IIB) 
skeletal muscle is highly dependent on its previous activation history. Rapidly fluctuating 
intramuscular conditions following intense excitation can modulate the function of force-
producing crossbridge interactions. These factors coalesce to attenuate maximal force 
production (Fmax) and velocity of shortening (V max), a phenomenon known as muscular 
fatigue. This effect has been attributed to both central and peripheral factors that alter the 
transmission and response of the molecular motor to motor unit activation. End-product 
inhibition and altered calcium (Ca2+) handling have been established as the important 
mechanisms leading to altered excitation-contraction coupling (ECC) and subsequent 
fatigue (Allen, Lamb, & Westerblad, 200Sb; Fitts, 200S). 
The observation that previous contractile activity can augment the force response 
to low frequency stimulation (Bowditch, IS71; Brown & Tuttle, 1926; Lee, 1906) 
suggested that mechanisms, which combat the functional losses associated with muscular 
fatigue, might exist in skeletal muscle. One such mechanism is the contraction-activated 
process of myosin regulatory light chain (RLC) phosphorylation, which has been shown 
to potentiate muscle twitch force in skeletal muscle following a variety of conditioning 
stimuli. Myosin RLC phosphorylation occurs during muscle contraction when Ca2+ 
released from the sarcoplasmic reticulum (SR) binds to intracellular calmodulin (CaM) to 
activate the skeletal muscle isoform of myosin light chain kinase (skMLCK) (Manning & 
Stull, 1979; Manning & Stull, 19S2). The outcome of this biochemical process is a 
structural change in the myosin molecule that renders the myofilaments more sensitive to 
intracellular calcium concentrations (Ritz-Gold, Cooke, Blumenthal, & Stull, 19S0). 
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Structural change in the mYOSIn head is best described as a bending or cocking 
movement; an alteration that shifts the population of myosin heads into a disordered array 
surrounding the thick filament. In this temporary state, each myosin head is thought to 
improve the opportunity for strong crossbridge interactions upon Ca2+ activation. Among 
the most important objectives in the study of myosin RLC phosphorylation is to elucidate 
(at the cellular level) the structural and functional response of the contractile apparatus to 
repeated contractions. Force potentiation has been implicated as a biochemical 
mechanism present in fast twitch skeletal muscle that may offer fatigue-resistant 
contractile benefits by inducing a leftward shift in the force-pCa curve at submaximal 
stimulation frequencies (Vandenboom, Grange, & Houston, 1993; Vandenboom & 
Houston, 1996; Zhi et aI., 2005). This feature suggests an increased affinity of myosin 
crossbridges for binding sites on the thin filament and a relative increase in the number of 
strongly bound crossbridges in response to submaxima! intracellular [Ca2+]. Additional 
studies have shown that increased Ca2+ sensitivity by means of RLC phosphorylation can 
ameliorate the depression in muscle twitch force during prolonged contractile activity, 
suggesting that this mechanism may function independently of the source of fatigue 
(Vandenboom & Houston, 1996; Vandenboom et al., 1997). The proposed relationship 
between these concurrent muscle history dependent phenomena is that myosin RLC 
phosphorylation is an intrinsic, adaptive mechanism that maintains contractile function 
amidst progressive weakening of muscular activation and the sensitivity of the contractile 
apparatus to activation during fatigue. The fact that myosin RLC phosphorylation is 
simultaneously triggered with the same signal as muscular contraction suggests that it 
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plays an central role in the physiological design and function of fatigable type II fibers in 
vivo. 
Recent technological advances in the manipulation of genetic sequencing and 
protein expression have established the novel ability to conduct robust mechanistic 
experiments with new insight. Zhi et al. (2005) generated skMLCK knockout mice to 
examine the physiological role of RLC phosphorylation in contractile performance. EDL 
muscles from skMLCK knockout mice exhibited no increase in RLC phosphorylation in 
response to repetitive electrical stimulation. Furthermore, in these muscles, twitch force 
was potentiated significantly less (>5% vs. 2:70%) than wild type mice in response to a 
conditioning stimulus (Zhi et aI., 2005). These results confirm that RLC phosphorylation 
by Ca2+/calmodulin-dependent skMLCK is the primary mechanism for twitch 
potentiation in fast-twitch skeletal muscle. 
The concept that RLC phosphorylation functions as a mechanism that may 
transiently ameliorate myofibrillar fatigue has been challenged by Karatzaferi et al. 
(2008) who suggested that myosin RLC phosphorylation may act synergistically with 
intracellular conditions that approximate fatigue to inhibit shortening velocity up to 
~40%. This outcome directly opposes previous findings (Persechini, Stull, & Cooke, 
1985) and encourages additional exploration into the biochemical mechanism of RLC 
phosphorylation within the metabolic accumulation model of muscle fatigue. Examining 
the specific role that RLC phosphorylation plays in modulating contractile performance 
during repetitive high frequency stimulation that leads to fatigue is especially difficult 
because this type of muscle activation cannot be studied without concurrently elevating 
RLC phosphate content. Therefore, a new definitive role for force potentiation in fatigue 
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resistance may not be clear until repeated contractile activity can be induced in the 
absence of RLC phosphorylation. 
The proposed study was designed to explore whether myosm RLC 
phosphorylation offers a fatigue resistant benefit to fast mouse muscles (EDL) during 
repetitive stimulation. Our primary intervention (skMLCK knockout) was expected to 
selectively eliminate myosin RLC phosphorylation and twitch force potentiation without 
influencing maximal force production or shortening velocity. The present results 
demonstrate that skMLCK gene ablation effectively removed myosin RLC 
phosphorylation, an intervention that attenuated contractile performance in KO muscles 
without a significant metabolic cost. Accordingly, muscle twitch force was protected in 
WT muscles to a greater extent during the initial stage of fatigue. As hypothesized, peak 
tetanic force (Po) and shortening velocity (Vo) were not influenced by skMLCK 
knockout. However, the almost two-fold increase of +dP/dt observed in WT muscles 
suggests that elevated myosin RLC phosphorylation has the potential to maintain high 
frequency force production during brief contractions even at high frequencies. The 
secondary analysis of +dP/dt established that shortening-induced deactivation (SID) is 
significantly larger in the presence of myosin RLC phosphorylation. This is a novel 
finding because it demonstrates that myosin RLC phosphorylation may also improve the 
rapid detachment of force-producing crossbridges in addition to rate of force 
development. In conclusion, myosin RLC phosphorylation improves the rate and extent 
of force production, which may maintain contractile performance during progressive 
fatigue. 
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II. REVIEW OF LITERATURE 
2.1.0 Background 
Muscle twitch force potentiation has been implicated as a characteristic of fast 
twitch skeletal muscle that may offer fatigue resistant contractile benefits by inducing a 
leftward shift in the force-pCa curve at submaximal stimulation frequencies (Grange et 
aI., 1995; Grange et aI., 1998; Vandenboom et aI., 1993; Vandenboom et at, 1995; 
Vandenboom & Houston, 1996; Vandenboom et aI., 1997; Zhi et aI., 2005). 
Characterization of skeletal muscle potentiation in recent decades has used a wide variety 
of methods. The gamut of these approaches ranges from robust cellular measurements of 
force and contraction kinetics to performance driven study of whole body dynamic 
movements. Fragmentation of potentiation research has resulted in specializations that 
differ meaningfully in the ability to characterize either a) the functional role of 
potentiation in human performance, or b) an accurate neuromechanical model of 
potentiation at the cellular level. Explaining the physiological relevance of skeletal 
muscle potentiation in human performance, however, may be difficult to elucidate until 
the precise cellular mechanisms are systematically determined. 
The purpose of this review is to present a summary of biochemical and functional 
characteristics associated with skeletal muscle potentiation. In addition, it will present the 
most recent data describing the cellular mechanisms of fatigue and provide the rationale 
for continued study into the coincidence of these phenomena. Of special interest is the 
regulation and functional significance of an important contraction-activated process: 
myosin regulatory light chain (RLC) phosphorylation. 
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2.1.1 Muscle Mechanics: Experimental Models 
Myosin RLC phosphorylation and muscle mechanics are studied using a variety 
of experimental models. In general, the most controllable experimental models are the 
most effective for mechanistic study but may lack physiological relevance to in vivo 
function. Of particular importance to the present discussion is the use of the skinned-fibre 
model. For these experiments, fast twitch fibres are extracted from an anesthetized animal 
and are carefully prepared by the chemical disruption of all structures other than the 
myofilaments (i.e., the contractile apparatus). Control of the physiological solution that 
surrounds the preparation is important as it contains important metabolic substrates and 
the Ca2+ that ultimately activates crossbridge cycling. This is the only model where 
intracellular [Ca2+] can be varied to directly test mechanical function at different levels of 
activation. The force-pC a relationship refers to the force response of a skinned-fiber to a 
range of Ca2+ concentrations (see Figure 4 for schematic). It is within this model that the 
calcium sensitivity of the contractile apparatus can be directly assessed by various 
interventions; such as the chemical phosphorylation of the myosin RLC or the addition of 
various metabolites and modulators of contractile function. 
2.2.0 Skeletal Muscle Microanatomy: The Contractile Apparatus 
The function of skeletal muscle is to convert stored chemical energy into 
mechanical energy. All biological movements involve cyclic interactions between 
specialized motor proteins, resulting in the generation of muscular force. The seminal 
sliding filament theory represented years of careful research conducted most prominently 
by H.E. Huxley and colleagues (Hanson & Huxley, 1953; H. Huxley & Hanson, 1954; H. 
E. Huxley, 1953; H. E. Huxley, 1957). Although initially controversial and difficult to 
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substantiate, the basic concept of cross-striated myofilaments and the chemically driven 
power stroke has remained virtually unchanged for half a century. Technological 
advances in the ability to isolate and view tissue at the microscopic level has allowed 
researchers to further characterize the structural components comprising one of nature's 
most impressive designs. 
Each individual contractile unit of a single muscle fibre (sarcomere) contains a 
network of thin (actin) and thick myofilaments (myosin) that are spatially oriented to 
maximize opportunities for direct physical interactions. Actin filaments are directly 
bound to the longitudinal ends (Z-line) of the sarcomere, while myosin is suspended at 
the midpoint (M -line) and anchored to the Z-line by the structural protein titin. When 
skeletal muscle is stimulated by peripheral alpha-motor neurons, every sarcomere along 
each fibre contracts synergistically as each myosin head 'pulls' the actin filament towards 
the M-line (H. E. Huxley, 1957; H. E. Huxley, 1969). This minute force-producing 
interaction of muscle proteins is turned into coordinated movement by the control of 
motor unit firing rates of antagonistic muscle groups attached to the appendicular 
skeleton. 
The thin filament is formed by two actin monomers (~40kDa) bound in a helical 
configuration. Each regulatory protein complex oftroponin (Tn) and tropomyosin (Tm) is 
longitudinally bound to seven actin molecules and is responsible for control of muscle 
contraction and propagation of cooperative myosin binding information (Gordon, 
Homsher, & Regnier, 2000). Actin subunits (TnC, Tnl and TnT) function to control the 
position of Tm on the thin filament, regulating the availability of actin binding sites for 
weak or strong interactions with myosin. Calcium (Ca2+) release from the sarcoplasmic 
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reticulum (SR) and subsequent binding to the specialized troponin subunit receptor (TnC) 
activates muscle contraction. As Ca2+ binds to TnC conformational changes are induced 
by weakening of the Tnl-actin complex and strengthening of the Tn-Tnl complex, a 
process that results in parallel sliding of Tm over the actin surface (Gordon, Homsher, & 
Regnier, 2000; Gordon, Regnier, & Homsher, 2001). Additionally, Tm facilitates 
communication along the thin filament to coordinate simultaneous availability of actin 
binding sites for myosin. More detailed characterizations of the thin filament regulatory 
protein complex have emerged but will not be discussed further in this review. 
The largest muscle protein, myosin, consists of two heavy chains (~200kDa) and 
two pairs of light chains (~20kDa), referred to as the essential light chain (ELC) and the 
regulatory light chain (RLC). Many myosin isoforms exist across various species; 
however, the myosin II isoform is especially abundant in vertebrate skeletal muscle. 
There are two distinct structural regions of the myosin molecule, known as the head and 
tail. Dimerization of heavy chains forms the rod-like tail component opposite to the 
globular amino-terminus, which diverges into two distinct 'heads' (Rayment et aI., 1993). 
Essential 
Light Chain 
! 
Myosin Heavy Chain 
1 
Figure 1. Myosin head microanatomy and important functional domains (Rayment et al. 1993). 
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The union of these distinct structural domains is an important functional location 
referred to as the neck and contains the essential and regulatory myosin light chains. In 
addition, the light chain binding domain located at the neck has been implicated as the 
lever arm during the power stroke of muscle contraction (Gulick & Rayment, 1997; 
Rayment et aI., 1993). Each of the globular heads of myosin contain a nucleotide binding 
pocket as well as an actin binding domain which are essential to the force generating 
capacity of the contractile apparatus. More detailed references to the myofibrillar 
complex will be discussed as needed in explanation of crossbridge cycling, myosin RLC 
phosphorylation and mechanisms of cellular fatigue. 
2.3.0 The Crossbridge Cycle & Regulation of Muscle Contraction 
Cyclic conversion of chemical energy (ATP) to mechanical force (sarcomere 
shortening) is a dynamic process known as the crossbridge cycle. It can best be described 
as a series of conformational state changes in the myosin molecule and biochemical 
interactions between the thick and thin myofilaments CH. E. Huxley, 1969). Muscular 
contraction is a result of asynchronous, force-producing crossbridge interactions with the 
thin filament. Crossbridge cycling in this manner ensures that the number of crossbridges 
bound during contraction does not fall drastically due to simultaneous detachment, an 
event that would make coordinated movement virtually impossible. Each crossbridge 
independently harnesses the energy liberated from the hydrolysis of A TP to produce a 
conformational change known as the power stroke. Modulation of structural changes in 
the myosin head is controlled by the contents of the nucleotide-binding pocket (Cooke, 
1997). The cycle begins with stearic ATP binding to the myosin head, which is 
subsequently hydrolyzed by myosin ATPase. Upon thin filament activation, the myosin 
9 
head can weakly bind to the actin filament with the ATP hydrolysis products (ADP and 
Pi) bound to the nucleotide-binding pocket. Release of Pi triggers a transition from weak 
to strong myosin binding and results in the power stroke. The power stroke is produced 
by a rotation of the light-chain binding domain of ~45°, displacing the thin filament 
longitudinally (~1Onm) towards the M-line of the sarcomere (McKillop & Geeves, 1993; 
Rayment et aI., 1993). Upon completion of the power stroke the crossbridge is in a rigor 
state and modulation of the actin-myosin interaction must take place before detachment 
can occur. ATP is rebound to the nucleotide-binding site and subsequently hydrolyzed as 
the myosin head detaches from the thin filament (Gordon et aI., 2000). 
The thin filament is regarded as the regulatory myofilament because it exists in 
various conformational states that alter the affinity of actin binding sites to crossbridge 
interactions. The three-state model described most notably by McKillop and Geeves 
(1993) suggests that the thin filament exists in a dynamic equilibrium between blocked, 
closed and open states. The thin filament regulatory complex (TnC, Tnl, TnT, Tm) 
sterically blocks actin-binding sites during the blocked state (relaxation). Upon activation 
(Ca2+ binding to TnC), tropomyosin rolls along the surface of actin and partially exposes 
actin-binding sites ( closed state). Crossbridges bound to the thin filament in the closed 
state form only weak biochemical interactions, initially. The cooperative effect of weakly 
bound crossbridges causes tropomyosin to roll further, fully exposing actin-binding sites 
(open state) for strong myosin interactions (power stroke). The thin filament will only 
remain in the open state in the presence of elevated myoplasmic [Ca2+] and strongly 
bound crossbridges (Vandenboom, 2004). Regulation of crossbridge cycling and muscle 
contraction is modulated in the following way: 1) movement of the thin filament 
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regulatory protein complex is dependent on myoplasmic [Ca2+] and the relative 
abundance of weakly or strongly bound crossbridges, 2) tropomyosin propagates signals 
of state changes (blocked-closed or closed-open) along the thin filament, 3) a power 
stroke can only proceed once Pi has been released, 4) affinity of crossbridges to actin 
binding sites is decreased when A TP is bound to the nucleotide pocket but increased 
upon hydrolysis (McKillop & Geeves, 1993; Rayment et aI., 1993). 
The theoretical model described above does not function optimally under all in 
vivo conditions. Dynamic physiological environments include fluctuations in calcium 
release, pH, temperature, muscle length, metabolic byproducts, and substrate availability 
that can impair ECC coupling (Allen, Lannergren, & Westerblad, 1995; Allen, Lamb, & 
Westerblad, 2008b; Cooke, 2007; Fitts, 2008). Of particular importance to the present 
review are acute causes of fatigue; impaired calcium release and accumulation of 
metabolic bypro ducts (see Appendix 4), which impair optimal contractility. 
2.4.0 Muscle Memory & Contractile History 
Among the most fascinating characteristics of skeletal muscle is that previous 
contractile activity can significantly alter subsequent performance, a phenomena often 
described as muscle memory. This concept was experimentally documented as early as 
the mid 19th century, a period of time in which novel explanations of muscle contractility 
were first developed by the pioneers of muscle physiology. Evidence of potentiated 
contractility following stimulation (Bowditch, 1871; Brown & Tuttle, 1926; Lee, 1906) 
suggested the existence of adaptive mechanisms that could at least temporarily improve 
muscle performance. This review is based on presenting a theoretical foundation for 
exploring skeletal muscle potentiation and how improved functional response to muscle 
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excitation could significantly attenuate the fatigability of fast twitch skeletal muscle. The 
role of myosin RLC phosphorylation in slow twitch muscle will not be discussed as the 
phenomenon of force potentiation does not exist in these myosin isoforms. 
2.5.0 Skeletal Muscle Fatigue 
Fatigue can be described as functional impairment of contractility, which is the 
direct result of altered muscle activation and crossbridge cycling. Prolonged muscle 
activation in vivo and through external stimulation can produce fatigue. The duty cycle 
(work:rest ratio) and stimulation intensity largely determine the amount of fatigue 
induced in skeletal muscle. Characterizing the mechanisms of fatigue during dynamic in 
vivo activity is extremely complex; therefore, this review will be limited to introducing 
the most important causes of fatigue and explaining how they might alter optimal 
contractility. The majority of applied research on fatigue has been conducted using 
isolated animal models, and therefore will be referred to support proposed theoretical 
mechanisms of fatigue. 
The two types of fatigue most often cited are high frequency fatigue (HFF) and 
prolonged low frequency force depression (PLFFD), previously described as low 
frequency fatigue (LFF). Each term refers to the modality in which the fatigue-related 
decline in performance is measured. HFF is the impaired ability to develop maximal 
tension in response to high frequency muscle activation and is generally attributed to a) 
elevated extracellular [K+], and b) failure at the neuromuscular junction (Allen, Lamb, & 
Westerblad, 2008b). This experimental model is most applicable to human tasks such as 
heavy lifting and maximal isometric contractions. PLFFD describes an impaired tension 
response to low frequency stimulation (twitch) without a concomitant impairment in high 
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frequency stimulation (tetanus). This phenomenon can last hours and possibly even days 
and is most prevalent at stimulation frequencies that correlate to low and moderate 
activities in humans (Rassier & Macintosh, 2000; Vandenboom & Houston, 1996). 
PLFFD is most likely caused by impaired calcium release and reduced myofibrillar Ca2+ 
sensitivity, which is the result of either disrupted calcium release channels or the 
precipitation of calcium phosphate (Ca3[P04h) in the SR (Allen, Lamb, & Westerblad, 
2008a; Posterino & Dunn, 2008). In humans, PLFFD could explain the period of 
weakness felt after an intense bout of exercise, especially activities involving muscle 
stretch and resultant structural damage. Regardless of whether any functional deficits 
exist in producing maximal muscle tension, activities requiring low to moderate 
stimulation frequencies may be altered in response to PLFFD. Skeletal muscle 
potentiation may therefore play a significant role in improving contractile performance 
deficits that persist far beyond the time course required for metabolic recovery from 
activity (Allen, Lamb, & Westerblad, 2008b; Rassier & Macintosh, 2000). 
2.6.0 Myosin Heavy Chain Phenotypes: Influence of Fibre Type 
Structural and functional differences exist between different fibre types in skeletal 
muscle. Muscle types are classified based on the expression of different myosin heavy 
chain isoforms; type I, IIA, IIX and lIB. Although under considerable debate, recent 
evidence exists that aJ muscle fibres can contain different myosin isoforms, and b) 
maximal shortening velocity between muscle cells with the same MHC expression is 
variable (Bottinelli, 2001; Pette & Staron, 2000). Therefore, the relationship between 
genetic expression of muscle protein isoforms and contractile properties is very complex. 
Type I fibres are far more fatigue resistance than type IIA and lIB fibres, although 
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oxidative capacity of type IIA fibres in rats is larger than type I fibres (Baldwin, 
Klinkerfuss, Terjung, Mole, & Holloszy, 1972). Type II fibres rapidly exhibit fatigue 
deficits in response to repeated contractions, and are commonly implicated in high 
intensity muscle performance due to their important role in developing maximal tension 
and rate of force development. 
The beneficial effects of myosin RLC phosphorylation on contractile performance 
are present in type IIX and IIB fibres only. Twitch force potentiation and myosin RLC 
phosphorylation are absent in muscles with high proportions of Type IIA and I fibres, 
even in the presence of elevated skMLCK (Ryder et al. 2007). 
2.7.0 Metabolite Accumulation & the Role of Calcium 
During muscular work, flux through metabolic pathways increases in response to 
changing energy demands. Maintaining [ATP] is vital to provide the chemical energy to 
fuel crossbridge cycling, Na+/K+ pumps and SR Ca2+ reuptake. However, during high 
intensity activity or continuous work, fast-twitch muscle can consume ATP much faster 
than it can regenerate it, resulting in accumulation of metabolic byproducts (see 
Appendix 4). Allen et al. (2002) used the firefly luciferinlluciferase reaction to monitor 
intracellular ATP concentration in single mouse skeletal muscle fibres. Their results 
suggest that although [ATP] declines significantly during fatigue (~20-30%) it cannot be 
a major cause of contractile dysfunction: a conclusion that substantiates the accumulation 
model and the idea of end-product inhibition. At low energy demand, the creatine kinase 
(CK) reaction buffers ADP accumulation by regenerating ATP through the following 
reaction: PCr + ADP ~ ATP + Cr. As [PCr] reaches low levels, [ATP] decreases rapidly 
and [ADP] accumulates in the myoplasm (Chase & Kushmerick, 1995; Cooke & Pate, 
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1985). During intense exercise, nucleoside diphosphate kinases can further buffer rises in 
[ADP] and re-synthesize ATP by facilitating reactions with other cellular high-energy 
phosphate donors (resulting in the accumulation of AMP, IMP). The accumulation of 
specific metabolic byproducts can impair actin-myosin interactions and Ca2+ handling 
(release and uptake) during muscle contraction. Appendix 4 provides a table of values 
that summarize the changes in metabolite concentrations that occur in skeletal muscle 
during fatigue. Additional factors such as muscle temperature, pH, duty cycle (work: rest 
ratio), and O2 availability are dynamic during repeated contractions and interact 
simultaneously to impair muscle performance. The following sections will outline the 
functional manifestations of fatigue and refer to the putative mechanisms involved. 
2.8.0 Contractile Function During Fatigue 
The direct result of repeated, asynchronous crossbridge power strokes is the 
production of longitudinal forces, known as active muscle tension. Muscular contraction 
is activated by calcium released from the SR in response to nervous stimulation. In 
principle, altered contractile performance observed during fatigue could be caused by: a) 
reduced myoplasmic [Ca2+] during contraction, b) reduced tension produced per 
crossbridge and number of crossbridges in the force-producing state, c) reduced 
sensitivity of the myofilaments to Ca2+, or d) altered rate of ECC. The force-pCa curve is 
a graphic representation that describes how much tension a muscle fibre can produce in 
response to a given myoplasmic [Ca2+]. Alterations in Ca2+ sensitivity of the myofilament 
shift the force-pCa curve, an effect that results in different contractile responses to a 
given [Ca2+] signal during contraction. In fatigued skeletal muscle, this represent an 
alteration in EC coupling. Allen and Westerblad (1989) studied free myoplasmic [Ca2+] 
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in isolated frog skeletal muscle fibres and concluded that [Ca2+] release and reuptake are 
attenuated during fatigue. This resulted in a rightward shift of the force-pCa curve 
(decreased Ca2+ sensitivity), at least partially explaining the reduction in tension and 
slowed rate of relaxation after fatiguing tetani. The authors suggested that impaired Ca2+ 
release during fatigue might be due to alterations in calcium release channels or a 
reduction in SR [Ca2+]. One important mechanism implicated in reduced SR [Ca2+] is the 
precipitation of calcium phosphate in response to elevated [Pi] during fatigue (Kabbara & 
Allen, 1999). 
Inability to develop maximal tetanic force (Fmax) at saturating [Ca2+] suggests that 
factors other than calcium release may cause impaired contractility at the crossbridge 
level. Accumulation of Pi and hydrogen ions (Hl have been linked to altered crossbridge 
function during fatigue. Studies using skinned fibres have shown that Fmax decreases 
exponentially with increases in [Pi], which can accumulate to 20-30mM during fatigue 
(Altringham & Johnston, 1985; Cooke & Pate, 1985; Debold, Dave, & Fitts, 2004). The 
general explanation for this effect is that accumulation of Pi may inhibit the crossbridge 
power stroke by inhibiting the release of Pi from the nucleotide-binding pocket, and in 
general causes a rightward shift in the force-pCa curve. Accumulation of Pi, however, 
does not significantly alter V max (Cooke & Pate, 1985; Debold et aI., 2004). 
The effect of increased [ADP] during fatigue has been shown to increase force 
production by ~1O% (Chase & Kushmerick, 1995; Cooke & Pate, 1985). The putative 
mechanism involved is that ADP accumulation may delay crossbridge detachment, 
resulting in longer strongly bound crossbridge associations. Despite this apparent fatigue 
resistant property, increased [ADP] has also been shown to significantly reduce Vmax in 
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skinned muscle fibres and isolated mouse skeletal muscle (Cooke & Pate, 1985; Metzger, 
1996; Westerblad, Allen, Bruton, Andrade, & Lannergren, 1998). As crossbridge 
detachment (ATP binding and hydrolysis) represents the rate-limiting step in the 
crossbridge cycle, the accumulation of [ADP] considerably attenuates ADP release- and 
the subsequent binding of ATP. The net effect of increased [ADP] in skeletal muscle 
therefore remains an impairment of contractile performance. 
Historically, the effect of muscle acidosis on contractile function has been a 
heavily debated topic. Flux through anaerobic glycolysis in fast twitch skeletal muscle 
can result in up to a ten-fold increase in [H+] over resting values (Allen, 2004). Early 
studies showed that pH decreases during fatigue and is associated with decreases in Fmax 
and V max. These studies used a skinned-fibre model and confirmed that decreasing pH 
from ~ 7 to ~6 resulted in an ~ 40% decrease in V max and ~50% decrease in Fmax (Fabiato 
& Fabiato, 1978; Godt & Nosek, 1989). Skinned fibre models represent a highly 
controllable (though non-physiological) representation of muscle contraction in which the 
muscle membrane has been chemically dissolved- leaving only the contractile apparatus 
intact. Muscle contraction is therefore regulated by the addition of specific concentrations 
of Ca2+ into the muscle bath itself. It has been suggested that H+ may compete with Ca2+ 
for binding to TnC (thus reducing thin filament activation), and additionally, that 
muscular acidosis may reduce the amount of energy liberated from the hydrolysis of ATP 
(Westerblad, Allen, & Lannergren, 2002). However, the role of reduced pH during 
fatigue may only be important at sub-physiological temperatures, questioning the 
physiological validity of past observations. Recent analysis using skinned muscle fibres 
have shown that at physiological temperatures fatigue may occur independent from 
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reductions in pH (Allen, 2004). It is increasingly apparent that Ca2+ signaling and 
sensitivity of the contractile apparatus to myoplasmic [Ca2+] plays a central role in 
fatigue (Allen & Westerblad, 2001; Allen, Lamb, & Westerblad, 2008b; Bruton, 
Lannergren, & Westerblad, 1998; Westerblad & Allen, 1991). Accumulation of 
metabolic byproducts in the myoplasm can inhibit optimal cross bridge cycling and the 
sensitivity to myoplasmic [Ca2+], which functionally impair muscle performance. 
Mechanisms that could improve or maintain contractile function in the presence of 
reduced myoplasmic [Ca2+] and crossbridge dysfunction could therefore be highly 
beneficial for muscle performance. Furthermore, an increased force response to a given 
stimulus (Ca2+ sensitivity) could theoretically improve muscle economy and delay fatigue 
by sparing the activation component of muscle contraction (see Appendix 5 for schematic 
and explanation). Skeletal muscle potentiation has been implicated as such a mechanism, 
although an exact physiological role has remained elusive. This discussion will continue 
by presenting the mechanism of skeletal muscle potentiation and explain its role m 
modulating contractility during a variety of environmental parameters. 
2.9.0 Skeletal Muscle Potentiation 
The observation that previous muscle contractile activity can modulate 
subsequent muscular performance can be traced back to as early as the mid 19th century 
(Bowditch, 1871; Brown & Tuttle, 1926; Lee, 1906). This effect was termed 'treppe', 
which directly translated into English means staircase. Lee (1906) postulated that this 
phenomenon was caused by either a) a benefit caused by chemical substances formed 
during catabolism, or b) by the production of heat from metabolic processes. New 
methods of isolating skeletal muscle tissue have since developed, and rodent tissue is 
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used in addition to previous research using skeletal and cardiac muscle from amphibians. 
Close and Hoh (1968) conducted experiments on whole rat muscle (EDL) suspended in a 
Ringer solution, measuring posttetanic potentiation (PTP) at 35° C. Their results 
characterized important characteristics of skeletal muscle potentiation such as; a) the 
intensity (frequency & duration) of a stimulus can alter the kinetics of a muscle twitch, b) 
environmental factors such as temperature and pH can alter a contractile response, and c) 
PTP is likely related to ionic accumulation in the muscle. The study of the history 
dependence of skeletal muscle contractility has therefore specifically attempted to 
characterize the structural and functional responses of the myofilaments to repeated 
contractions at the cellular level. Within the study of human muscle performance, it is of 
special interest to establish how the act of a 'warm-up' activity or conditioning stimulus 
may acutely influence muscle performance during high intensity activities. 
2.10.0 Myosin RLC Phosphorylation 
During muscle contraction, Ca2+ released from the SR is an important regulator of 
myofilament function. In addition to activating the thin filament regulatory complex (as 
explained previously), myoplasmic Ca2+ binds to calmodulin and subsequently activates 
myosin light chain kinase (skMLCK). Early experiments by Manning and Stull (1979) 
measured myosin RLC phosphorylation in isolated EDL muscles from Sprague-Dawley 
rats at rest, during tetani and following relaxation. They concluded that phosphorylation 
of the myosin light chain was temporally correlated with a transient potentiation of 
posttetanic twitch force. This process is non-acutely reversed following activation by 
myosin light chain phosphatase, which de-phosphorylates the RLC (Morgan, Perry, & 
Ottaway, 1976). 
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Figure 2. Myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) regulate 
the phosphate content of the regulatory light chain. MLCK is activated with muscle contraction as 
intracellular [Ca2+] increases rapidly (Manning & Stull, 1982). 
The functional alterations associated with potentiation are thought to occur during 
the temporal lag between muscle inactivation (declining myoplasmic [Ca2+]) and the slow 
dephosphorylation of the RLC (Manning & Stull, 1982). It is well understood that 
phosphorylation of the RLC causes a conformational change in the myosin crossbridge 
characterized as a bending or swivel, which may be caused by an interaction between the 
negatively charged phosphate and the negatively charged myosin tail (Ritz-Gold et aI., 
1980; Yang, Stull, Levine, & Sweeney, 1998). This change is understood to disorder the 
distribution of myosin heads around the thick filament. 
A- At rest, unphosphori!aled 
s- Myosin conformational change after RLC phosphOrylation 
C- Strongly-bOUnd myosin head (force-producing interaction) 
Figure 3. Myosin RLC phosphorylation causes a conformational change in the myosin head 
domain that improves the opportunity for strong crossbridge binding to the thin filament 
(Sweeney, et aI., 1993). 
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The implicated functional benefit of this conformational change is that a decrease 
in the interfilament spacing can improve the capacity to form weakly bound crossbridge 
interactions with the thin filament. RLC phosphorylation is therefore thought to improve 
the Ca2+ sensitivity of the contractile apparatus by shifting the force-pCa curve to the left. 
The conformational change associated with phosphorylation is thought to induce a 
disordered organization of the myosin filament vs. an ordered organization during rest. 
Yang et al. (1998) used permeabilized rabbit psoas fibres to determine whether 
decreasing the lattice spacing of the thick and thin filaments could mimic the 
physiological effects of phosphorylation. The effect of reducing interfilament spacing 
using osmotic pressure (wi Dextran) and increasing muscle length (muscle is 
isovolumetric) substantiated the interaction between interfilament spacing and improved 
Ca2+ sensitivity. However, RLC phosphorylation did not provide any additional 
contractile benefit to muscles compressed by osmotic pressure or increased length. 
2.10.1 Functional Outcomes ofRLC Phosphorylation 
Isolated mammalian skeletal muscle models of contractility allow researchers to 
control environmental factors and physiological variables that may confound whole body 
in vivo studies. The most robust of these models uses skinned muscle fibres, which retain 
an intact myofilament lattice following chemical disruption of the plasma membrane. 
Persechini et al. (1985) used skinned rabbit psoas fibres to further validate the association 
between RLC phosphorylation and twitch potentiation. Previous studies had not 
measured intracellular [Ca2+] as a potential confounding factor causing twitch 
potentiation; therefore, the authors intended to measure potentiation in phosphorylated 
muscle with constant [Ca2+]. Their results show that at 25°C myosin RLC 
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phosphorylation has little effect on twitch force at saturating free Ca2+ (1 O~), although a 
large effect at 0.6 ~. Maximum shortening velocity was unaffected by RLC 
phosphorylation indicating cross-bridge detachment rate is also unaltered. The 
physiological significance of these results is that RLC phosphorylation may only alter 
contractile performance at free [Ca2+] which are lower than those found during tetanic 
contractions in vivo. 
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Figure 4. The functional effects of myosin RLC phosphorylation on the force-pCa curve and twitch 
force potentiation. A) Myosin RLC phosphorylation induces a leftward shift in the force-pCa curve; 
a change reflecting increased calcium sensitivity (Persechini et aI., 1985). 8) Posttetanic 
potentiation following a conditioning stimulus. Twitch force is elevated almost 2-fold due to an 
increase in apparent rate of crossbridge formation (Zhi et. aI., 2005). 
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Metzger et al. (1989) subsequently designed a series of experiments to further 
elucidate the role of RLC phosphorylation on crossbridge interactions. Using skinned 
fibres from rabbit psoas and rat vastus lateralis, the authors explored the rate of force 
development (+dP/dt) after a step release before and after RLC phosphorylation. Their 
results indicate that RLC phosphorylation increases the rate of crossbridge attachment at 
moderate free [Ca2+], an effect that would increase the rate of tension development of a 
twitch following conditioning activity. In 1990, Sweeney and Stull conducted 
experiments also using skinned rabbit psoas fibres to further characterize the actin 
myosin interaction in response to RLC phosphorylation. Their results were analyzed 
using the two-state crossbridge model first described by Brenner (1988), which classifies 
the transition between non-foree-generating to force-generating states using the forward 
rate constant of crossbridge formation, fapp, and the reverse rate constant gapp. The 
general understanding is that myosin RLC phosphorylation induces a structural 
modification that repositions the myosin binding domain into a more favorable position, 
thus facilitating more effective strong crossbridge binding. Accordingly, it is inferred that 
cross bridge binding can occur sooner and to a greater extent when the myosin RLC is 
phosphorylated; establishing that myosin RLC phosphorylation augments the rate of 
force development by an increase in the rate constant fapp. Furthermore, the observation 
that gapp is unaffected by this mechanism substantiates the previous finding that RLC 
phosphorylation does not modulate maximal shortening velocity (Persechini et aI., 1985). 
In summary, the results of skinned fibre experiments provide compelling evidence for 
improved contractile performance mediated by RLC phosphorylation. The leftward shift 
of the force-pCa curve during RLC phosphorylation represents both an increased affinity 
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of the crossbridge to binding sites on the thin filament and a relative increase in the 
number of strongly bound crossbridges in response to submaximal Ca2+ (Persechini et aI., 
1985). Skinned fibre analysis, however, is not representative of in vivo conditions. These 
observations could be consistent with physiological function in vivo but without the 
experimental control of potentially confounding variables, these conclusions cannot be 
substantiated. However, these results do serve as a strong theoretical framework from 
which other models of skeletal muscle potentiation have developed. 
Grange, Vandenboom and Houston (Grange et aI., 1995; Grange et aI., 1998) 
conducted studies that applied the previous data from skinned fibre experiments to whole 
muscle (mouse, EDL) function in vitro (25°C). EDL muscles phosphorylated using a 20s 
conditioning stimulus (5Hz) exhibited potentiation of maximal isometric twitch force 
(13-17%) and rate of force development (9-17%)(Grange et aI., 1995). Importantly, all 
values correlated with a five-fold increase in RLC phosphorylation. The novel finding of 
potentiated displacement may also suggest a relevant correlation between RLC 
phosphorylation and whole body movement due to improved work and power (~22%). 
Studies conducted in 1998 were intended to determine the work and power response to 
single-twitch stimulations during sine cycles in potentiated mouse EDL. This study was 
intended to approximate previously documented increases in work and power under 
conditions that mimic in vivo function (i.e. locomotion), where load and velocity may 
vary as muscle length changes. The results indicated a potentiation of mean concentric 
work and power (25-50%), isometric twitch force and rate of force development (14%, 
12%) with a concomitant increase in RLC phosphate content (~3.7-fold). These data 
clearly highlight the importance of studying force-potentiation under dynamic conditions 
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and further reinforce the hypothesis that RLC phosphorylation may be an important 
mechanism which modulates muscle performance in vivo. 
2.10.2 Temperature & Length: Modulators of Ca2+ Sensitivity 
Skinned fibre experiments are highly controllable and reliable however, they are 
limited by a lack physiological relevance due to the absence of important in vivo 
conditions. The force-pCa curve can be altered by a variety of factors, but most 
significantly by changes in temperature and length. It is critical, therefore, to consider 
these factors when describing the physiological importance of RLC phosphorylation in 
vivo. Previous studies (Close & Hoh, 1968; Krarup, 1981; Stein, Gordon, & Shriver, 
1982) have highlighted the importance of temperature on muscle twitch contractility, 
suggesting the following: rate of force relaxation, shortening velocity and extent of 
tension potentiation decay proportionally with decreasing temperature, while the time 
course and peak tension are positively correlated to decreasing temperature. 
Moore et al. (1990) reported the effects of temperature (25°, 30° and 35° C) on 
contractile function in mouse EDL muscles. Following a conditioning stimulus (5Hz, 
20s) the extent of RLC phosphorylation and peak unpotentiated twitch tension was 
inversely proportional to temperature. These findings are supported by the concept that at 
low temperatures Ca2+ transients are larger and longer in duration, resulting in a larger 
activation of skMLCK and the thin filament. Moore et al. also observed more robust 
tension potentiation, increased rate of decay, and more rapid dephosphorylation as 
temperature increased. It is clear that the Ca2+ -sensitizing effect of RLC phosphorylation 
is more critical at higher temperatures that correspond to relatively lower [Ca2+] levels. 
Therefore, previous skinned fibre experiments conducted at 20-25°C may have 
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underestimated the significance of improved Ca2+ sensitivity (RLC phosphorylation) that 
occurs at physiological temperatures where [C;+] handling may be impaired. 
To mimic the leftward shift in the force-pCa curve due to RLC phosphorylation 
Yang et al. (1998) increased muscle length of skinned fibres to decrease interfilament 
spacing. These methods successfully increased the sensitivity of the myofilament to 
[Ca2+], but subsequent phosphorylation of the RLC had no additional effect on the force-
pCa curve. Similar conclusions have been made in a variety of experiments using rat 
gastrocnemius in situ and isolated mouse EDL fibres in vitro (Rassier, Tubman, & 
MacIntosh, 1997; Rassier, Tubman, & MacIntosh, 1998; Rassier & MacIntosh, 2002). 
The consensus is that improved Ca2+ sensitivity induced by myosin RLC phosphorylation 
diminishes as muscle length increases due to reduced interfilament spacing. This finding 
that intracellular Ca2+ transients were not altered by length changes in mammalian single 
fibres (Balnave & Allen, 1996) demonstrates that the reduction in observed potentiation 
at long muscle lengths is likely attributed to myosin RLC phosphorylation and not some 
Ca2+ effect. An additional study conducted by Rassier and Herzog (2002) revealed the 
effect of pH on the length dependence of force potentiation. The results of their study 
indicated that as pH increased (6.6 to 7.8), the length dependence of potentiation was 
abolished. Therefore, a decrease in pH could attenuate Ca2+ sensitivity by competing for 
thin filament binding domains. Although not discussed by the authors this association 
may be significant when speculating the benefit of potentiation during fatigue at all 
muscle lengths, given the decline in pH during intense activity (due to accumulation of 
H+ ions). 
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2.11.0 Coincident Potentiation & Fatigue During Repetitive Stimulation 
The idea that skeletal muscle force potentiation occurs in fast twitch muscle to 
resist fatigue is an attractive concept, yet at present, lacks conclusive evidence. It is clear 
that the physiological role of RLC phosphorylation is not regulatory, but may modulate 
contractility enough to be considered performance enhancing. An additional challenge in 
characterizing this relationship is the highly complex nature of fatigue, which may arise 
from central nervous failure, peripheral motor unit impairment, or ECC failure in the 
muscle. The following discussion will attempt to explore the coincidence of potentiation 
and fatigue by discussing the most significant literature that has addressed this issue. 
Vandenboom and Houston conducted a series of studies on fatigued mouse EDL 
muscle (Vandenboom & Houston, 1996; Vandenboom et aI., 1997) at 25°C, to determine 
the effect of RLC phosphorylation-mediated increases in Ca2+ sensitivity on the 
potentiation of maximal twitch force (PD and rate of force development (+dP/dt). 
Initially, the authors elicited muscle fatigue using high frequency tetanic stimulation 
(400Hz, 150ms) for 120s (Vandenboom & Houston, 1996). After ISs of stimulation, Pt 
was potentiated ~18% while RLC phosphorylation was increased four-fold. Subsequent 
Pt measures continued to decline despite elevated RLC phosphate content, suggesting that 
potentiation was not strong enough to overcome the effects of HFF. During additional 
experiments, a LFF protocol was used to depress peak tetanic force (Po) and twitch force 
CPt) by ~ 80% and 67%, respectively. Following a conditioning stimulus, myosin RLC 
phosphorylation and twitch force were elevated above resting values for fatigued muscles 
(four-fold and 25%, respectively). These results indicated that increased Ca2+ sensitivity 
due to RLC phosphorylation abolishes the declines in twitch force during fatigue 
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(Vandenboom & Houston, 1996). In 1997, the same authors utilized a variety of 
experimental protocols to depress peak tetanic force production and stimulate RLC 
phosphorylation (Vandenboom et aI., 1997). Stimulation of the muscles at lower 
frequencies (2.S-20Hz) increased RLC phosphorylation (0.23-0.82 P-skRLC/Total-
skRLC), potentiated twitch force (4-28%) and rate of force development (5-28%). The 
novel finding from this study was that rate of force development could be augmented 
during fatigue and that increases were graded to contraction-induced RLC phosphate 
content. 
The previous studies suggest a number of important concepts relating to the 
potential fatigue resistant properties of RLC phosphorylation and twitch potentiation, 
summarized below. 
• Elevated RLC phosphate content following 120s of repeated tetani suggests that fatigue 
does not impair the underlying mechanism of twitch potentiation (RLC 
phosphorylation) . 
• The increase in Pt was similar during HFF and in non-fatigued muscle, proposing that 
the effects of RLC phosphorylation on twitch force development may be insensitive to 
myofibrillar fatigue. 
• Twitch potentiation remains a transient phenomenon during the early stages of HFF, 
suggesting that force-diminishing processes at the myofilaments eventually overcome 
any benefit ofRLC phosphorylation on Ca2+ sensitivity. 
It is clear that even at the single muscle level, the interaction between fatigue and 
force potentiation is dynamic and transient. Criticism of these experimental models 
surrounds the fact that conclusions are based on the single muscle twitch, lacking 
physiological relevance to actual motor unit fIring rates in vivo. The role of RLC 
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phosphorylation in attenuating the decline in Po during HFF is unknown and has proven 
difficult to elucidate. Despite this, the exact role of twitch potentiation in fatigue 
resistance may not be clear until similar HFF protocols are conducted in the absence of 
RLC phosphorylation (see skMLCK knockout, below). 
The coincidence of potentiation and fatigue has been documented by a variety of 
authors (Rassier & Macintosh, 2000; Rijkelijkhuizen, de Ruiter, Huijing, & de Haan, 
2005) who have attempted to characterize the various roles in which RLC 
phosphorylation may benefit muscular performance. An important distinction between 
fatigue and potentiation is that each has a vastly different time-course for recovery. 
Potentiation is an acute phenomenon that dissipates within minutes, whereas fatigue may 
last for hours (PLFFD). Therefore, the relationship between potentiation and fatigue 
undoubtedly varies depending on the specific physiological condition of the tissue. For 
example; at high temperatures increased Ca2+ sensitivity due to RLC phosphorylation is 
more beneficial than at low temperature. However, fatigue may be elevated at high 
temperatures due to a variety of factors therefore masking this benefit. The relative 
importance of potentiation during fatigue may depend on the specific effects of any factor 
that may alter the force-pCa curve or ECC. In addition, the authors suggested it may be 
beneficial to study the interaction of potentiation and fatigue during incompletely fused 
tetanic contraction that may be representative of voluntary muscle activation (Rassier & 
Macintosh, 2000). The significance of this work would be exploring whether force 
potentiation is evident during repeated stimulation at higher frequencies (i.e., IS-60Hz), 
giving this effect greater physiological credence as a fatigue resistant property. 
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The relative importance of potentiation in human muscle performance has been 
addressed by a number of researchers (Baudry & Duchateau, 2007; Fowles & Green, 
2003; Hodgson, Docherty, & Robbins, 2005; Sale, 2002). From a human systemic point 
of view, potentiation may provide a benefit in muscular performance in a few ways. First, 
potentiation may elevate submaximal force production so that a given force may be 
maintained at a lower motor unit firing rate, which may delay the onset of fatigue (see 
Appendix 5 for schematic). Producing a given submaximal force could potentially require 
less activation from the central nervous system in the phosphorylated state. This would be 
a functional outcome of increased Ca2+ sensitivity at the cellular level. Second, in the 
presence of PLFFD, potentiation may restore low-frequency force to near-pre fatigue 
levels, an effect that may attenuate prolonged ECC impairments or subjective feelings of 
weakness. 
In summary, the integrative study of potentiation and fatigue has produced many 
questions that remain to be clarified. Whole body research has suggested that although 
potentiation may be evident during performance, the mechanisms involved are complex 
and dynamic. In particular, the fact that only type II fibres exhibit force potentiation 
limits the significance of results found in mixed human muscle studies. Great care must 
be taken by researchers who assess contractile performance and fatigue processes to 
account for the effects of potentiation in their results. The coincidence of potentiation and 
fatigue has clearly been established; however it is now important to further elucidate the 
role of myosin phosphorylation during various fatigue conditions. These could highlight 
important dependencies on temperature and the response to various modulators of 
skeletal muscle contractility (ADP, Pi, W, Ca2+). 
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2.12.0 Recent Advances in the Study of Myosin RLC Phosphorylation 
2.12.1 Myosin Light Chain Kinase (skMLCK) Knockout 
Emerging technologies that use any type of genetic modification have become the 
topic of considerable ethical debate. From a scientific research standpoint, however, 
many of these breakthroughs provide an exceptional model for study. Among these is the 
concept of gene knockout, which involves the ablation of a specific gene to study a 
particular phenotypic characteristic associated with it. Geneticists at the Transgenic Core 
Facility at the University of Texas Southwestern Medical Center have recently developed 
independent breeds of mice that exhibit different expressions of the enzyme myosin light 
chain kinase. This advance permits an unprecedented ability to study potentiation in the 
absence or over-expression of its putative biochemical mechanism, myosin RLC 
phosphorylation. 
Prof. James Stull and colleagues have since used these mice in two noteworthy 
research studies to substantiate the mechanism of potentiation. Zhi et al. (2005) used 
skMLCK knockout mice to examine the physiological role of RLC phosphorylation. 
Their results showed that in isolated EDL muscle from skMLCK knockouts, there is no 
significant increase in RLC phosphorylation in response to repetitive electrical 
stimulation. Furthermore, EDL muscles from knockout mice potentiated significantly less 
than wild type mice in response to a conditioning stimulus. These results confirm that 
RLC phosphorylation by Ca2+/calmodulin-dependent skMLCK is the primary mechanism 
for twitch potentiation in fast-twitch skeletal muscle. This study produced two 
unexpected findings, however. First, knockout mice showed a small amount of RLC 
phosphorylation located near the serine residue phosphorylated by skMLCK. This 
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suggests the existence of additional kinases that are capable of phosphorylating the RLC. 
Alternate possibilities could be that this unknown kinase may be an adaptation to 
skMLCK knockout or that other isoforms of skMLCK could exist which may 
phosphorylate the myosin RLC. 
The second finding was that knockout mice showed a potentiated force response 
to staircase stimulation (up to ~30%). The authors suggested that myosin RLC 
phosphorylation contributes greater to twitch potentiation than staircase in response to 
low frequency stimulation for long durations. This effect on Ca2+ handling may be 
attributed to calmodulin effects on the dihydropyridine and ryanodine receptors (Zhi et 
aI., 2005). This concept was presented by Rassier & MacIntosh (2000), who suggested 
that the mechanism for enhancement for staircase and PTP during fatigue might be 
different. Furthermore, Rassier et al. (1999) noted that staircase might occur in the 
absence of RLC phosphorylation at low levels of Ca2+. Subsequent research was 
conducted by Ryder et al. (2007) on transgenic mouse EDL with enhanced skMLCK 
expression (~22 fold) to determine whether skMLCK or its putative activator Ca2+_ 
calmodulin (CaM) is limiting to twitch potentiation. The transgenic mice showed greater 
RLC phosphorylation and force potentiation in response to conditioning stimulation than 
wild type mice. Interestingly, transgenic soleus fibres exhibited significant myosin RLC 
phosphorylation but no twitch potentiation. This study provided additional evidence that 
myosin RLC phosphorylation contributes to muscle force potentiation in type lIB fibres 
but not type IIA or I fibres. Finally, given that the transgenic mouse EDL exhibited 
greater twitch potentiation than wild type mice, the authors suggested that skMLCK is 
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limiting and essential to myosm RLC phosphorylation in vivo rather than Ca2+_ 
calmodulin (Ryder, Lau, Kamm, & Stull, 2007). 
2.12.2 Myosin RLC Phosphorylation as a Contributor to Fatigue 
The concept of force potentiation as a mechanism that may counteract 
myofibrillar fatigue has been questioned in a series of experiments conducted by Dr. R. 
Cooke and colleagues at the University of California (Franks-Skiba, Lardelli, Goh, & 
Cooke, 2007; Karatzaferi, Franks-Skiba, & Cooke, 2008). Karatzaferi et al (2008) 
imitated in vivo fatigue conditions by varying the myosin light chain phosphorylation 
«10% to >50%); pH (7.0 to 6.2) and phosphate (5mM to 30mM) content of skinned fibre 
preparations using a temperature jump protocol (5 and 30° C). These authors showed that 
myosin light chain phosphorylation may act synergistically with increased Pi and 
decreased pH at 30° C to inhibit shortening velocity of fully activated muscle fibres 
(~40%.) It is important to note the temperature dependency of this effect, however, as 
experiments conducted at 10° C did not recapitulate these results. The manner in which 
temperature influences the intracellular environment during extreme fatigue remains 
unclear. There are two hypotheses that may explain the mechanism by which RLC 
phosphorylation may inhibit maximal shortening velocity. The first suggests that as RLC 
phosphorylation alters the structural configuration of the thick filament, disordered 
myosin heads can more easily interact weakly with the thin filament. These weak 
interactions may have a braking effect on the contractile apparatus during activation that 
may attenuate filament velocity (Karatzaferi et aI., 2008). This hypothesis is speculative 
and furthermore does not include an explanation for its sole existence during conditions 
with low pH and elevated Pi concentrations. The second gives explanation for altered 
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kinetics of the actin-myosin interaction by lowered pH, elevated Pi and myosin light 
chain phosphorylation. The authors discuss an altered affinity for nucleotides may 
account for slower shortening velocity. Although the sites of phosphorylation and ATP 
binding are not directly associated with each other spatially, there is a possibility that the 
two sites may interact biochemically to result in altered contractile properties. 
The conclusions reported above represent a novel concept questioning the 
physiological role of RLC phosphorylation. Is it possible that this biochemical process 
contributes to fatigue despite the previous body of research touting its existence as a 
fatigue resistant mechanism? The answer to this question remains equivocal but may 
partially be explained by the following ideas: 
• Extrapolating the physiological relevance of skinned-fibre experiments to whole 
muscle or in vivo contractile function may be problematic. Shortening velocity was 
limited only under circumstances that may not be considered physiological except 
under extreme circumstances (6.2 pH, 30mM Pi). It is important, however, that 
experiments were conducted at 30° C: much closer to physiological temperature than 
used by other contractile models. 
• Although not discussed, the data from Karatzaferi (2008) demonstrate that during all 
trials where Pi was elevated to 30mM, the addition of myosin phosphorylation 
increased the force-producing ability in skinned fibres (~4%). 
2.12.3 Myosin RLC Phosphorylation & the Energy Cost of Muscular Work 
The effect of posttetanic potentiation on muscular work and energy cost in 
skeletal muscle was studied on in situ rat gastrocnemius muscles by Abbate et al. (2001). 
The purpose of these experiments was to elucidate a clearer understanding of the 
ecomomy of skeletal muscle contraction in the 'potentiated' state. Contractile 
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perfonnance was measured during a sequence of 10 submaximal (60Hz) concentric 
contractions at rest (control) or following a short conditioning stimulus (potentiated). The 
conditioning stimulus used in these experiments was a sustained maximal tetanic 
contraction for I second (160Hz). Their results demonstrated that total work was 
potentiated to a greater extent following the conditioning stimulus (vs. the control group), 
but the relative energy cost of contraction was significantly greater. This finding suggests 
that energy cost of contraction is increased relatively more than mechanical output when 
myosin RLC phosphorylation is elevated. It is important to note, however, that the 
submaximal concentric contractions used to assess contractile perfonnance elevated the 
myosin RLC phosphate content to the same extent as the conditioning stimulus itself. 
Therefore, the control group itself was not studied in the absence of myosin RLC 
phosphorylation. The authors suggested that the increased number of strongly bound 
crossbridges available for binding in the phosphorylated state could possibly account for 
a higher rate of ATP turnover during repeated contractions. Furthennore, the addition of 
each phosphate to the myosin RLC represents an additional energy cost to muscular 
contraction. The experiments by Abbate et al. (200 I) may not completely account for the 
increased energy cost associated with the I-second conditioning stimulus, however. More 
important, the RLC phosphate content and total work output in the control (non-
potentiated) group was steadily increasing throughout the 10 concentric contractions, 
suggesting that these muscles were in a transitional state. These results highlight the 
numerous methodological concerns and future questions associated with studying myosin 
RLC phosphorylation. First, the choice of conditioning stimulus utilized to 'potentiate' a 
muscle is critical. Sustained contractions at high frequencies elevate the myosin RLC 
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phosphate content to a higher extent while concurrently inducing significant fatigue. The 
conditioning stimulus employed will therefore only highlight a different 'window' to 
study the coincidence of potentiation and fatigue. Second, assessing the costlbenefit 
relation of myosin RLC phosphorylation during muscle work is likely dependent on 
contraction type and stimulation frequency. For example, is the role of myosin RLC 
phosphorylation in modulating contractile function more or less important during 
isometric and/or eccentric contractions? Additionally, is the potentiation of muscle work 
at 20Hz more or less energy efficient than the 60Hz contractions studied by Abbate et al. 
(2001)? 
It seems plausible that the degree of myosin RLC phosphorylation for optimal 
mechanical efficiency of muscle contraction is variable and may depend on the type of 
muscle work being executed. Last, and most importantly, studying the net balance 
between contractile performance and energy cost establishes the rationale for determining 
whether myosin RLC phosphorylation truly exhibits fatigue resistant properties during 
fatigue. 
2.12.4 Shortening-Induced Deactivation (SID) 
Researchers have explored additional kinetic properties of skeletal muscle that 
modulate contractile performance. Through influential research by Edman (1975) with 
single skeletal muscle fibres, it was first observed that active shortening reduces a muscle 
fibre's ability to produce tension and that this depressant effect increased with the 
magnitude of shortening. These results suggested that the activation state of the thin 
filament (and regulatory protein complex) is affected during active shortening, leading to 
a transitory impairment of force-producing interactions between the thin and thick 
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filaments. Although the tenns relaxation and deactivation may seem interchangeable, 
they occur in response to distinct mechanisms. Relaxation has been cited as the decline in 
active force production following muscle activation. It is most often quantified as rate of 
relaxation and is calculated by finding the 'is relaxation time of the force-time profile. 
This process is mitigated by the re-sequestration of Ca2+ into the sarcoplasmic reticulum 
and is rate-limited by the activity of the SERCA Ca2+-ATPase pump. Shortening-induced 
deactivation (SID) refers to the rapid dissociation of Ca2+ and myosin crossbridges from 
the thin filament during active shortening (see below). 
Muscle Activation 
Thiel< Fnament 
Shortening-lnduced Deactivation (SID) 
Thick Filament 
\ 
@ 
Figure 5. The mechanism of Shortening-Induced Deactivation (SID). Rapid shortening of muscle 
length during active crossbridge cycling induces the inactivation of the actin filament as both Ca2+ 
and force-producing crossbridges dissociate from their respective binding domains. The extent of 
this deactivation is observed by a reduction in the subsequent rate of force development following 
the length shortening, which is governed by the rate at which Ca2+ and force-producing 
crossbridges can rebind to the actin filament. Thin filament deactivation, like activation, relies on 
both the Ca2+ occupancy of the thin filament as well as the number of strongly bound 
crossbridges (Le., cooperative binding model). The relative effect of each factor in causing 
shortening-induced deactivation is presently unknown, however. 
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As the relative ease to which myosin crossbridges can bind with the actin filament 
depends on the activation level of the thin-filament regulatory complex, the concept of 
SID is that the opposite process of deactivation occurs when the muscle undergoes 
shortening during a muscle contraction, allowing more efficient sliding of the thin 
filaments and possibly minimizing any negative forces exerted by a population of 
strongly bound crossbridges. This history-dependent mechanism in skeletal muscle was 
established as intracellular Ca2+ measurements were taken throughout a fused tetanic 
contraction in which various shortening protocols were induced (Vandenboom, Claflin & 
Julian, 1998; Jiang & Julian, 1999; Vandenboom, Hannon & Sieck, 2002). Jiang and 
Julian (1999) observed that intracellular [Ca2+] increased during rapid shortening and this 
mechanism was more extreme as the speed of shortening and magnitude of shortening 
increase. Importantly, these experiments established that the acute consequence of SID is 
the attenuation of the rate of force development (+dP/dt) following rapid muscle 
shortening. SID can therefore be observed by comparing the initial rate of force 
development during an isometric contraction with the rate of force development 
following a rapid shortening of muscle length. 
There are no reports at present that have specifically explored the effect of myosin 
RLC phosphorylation on SID. It is understood that SID represents a history-dependent 
mechanism that transiently decreases contractile performance (Edman, 1996). The 
rationale for exploring the influence of myosin RLC phosphorylation on SID is to 
establish whether the mechanism that potentiates rate of force development may also 
influence thin filament deactivation at various stages of fatigue. Given that muscle 
function in vivo is likely altered by SID during rapid cycles of activation during 
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concentric and eccentric work, the magnitude of deactivation and its influence on 
subsequent force redevelopment is of considerable importance to the current study. If 
total muscle work is determined by the work performed during each cycle of activation 
and the frequency of activation, SID may improve the ability of a muscle to rapidly 
deactivate at a small cost to the subsequent contraction (attenuated +dP/dt). The balance 
of these two factors may determine the effect of SID on contractile performance during 
fatigue. 
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2.13.0 Contractile Performance During Fatigue: A Brief Overview 
The various factors that influence contractile function during repetitive 
stimulation of skeletal muscle coalesce into a complicated model of peripheral/cellular 
fatigue. New technologies and models of research used in carefully controlled 
experiments can progressively be applied to improve the understanding of this model. 
The following schematic describes the relevant factors that may help determine whether 
myosin RLC phosphorylation can truly be described as a fatigue-resistant mechanism. 
Skeletal Muscle Fatigue: Factors Influencing Contractile Performance 
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Figure 6. The coincidence of myosin RLC phosphorylation and fatigue is a complicated system of 
positive and negative influences that modulate contractile performance in vivo. Environmental 
factors are highly dynamic during fatigue and influence all components of the system. 
40 
III. STATEMENT OF THE PROBLEM 
3.1.0 Central Research Question 
Does myosin RLC phosphorylation resist fatigue by maintaining the performance 
response of the contractile apparatus during repeated activation? 
The crucial problem is that fatigue cannot be studied in the absence of myosin 
RLC phosphorylation, as both occur concurrently during repeated muscle activation. 
Consequently, the specific physiological role of myosin RLC phosphorylation as a 
modulator of crossbridge function cannot be revealed until muscle performance during 
fatigue is studied in its absence. 
The proposed study was therefore designed to test whether EDL muscles from 
skMLCK knockout mice exhibit more fatigue compared to wildtype EDL muscles. 
Biochemical analysis supplements the investigation of contractile performance by 
quantifying the myosin RLC phosphate content and accumulation of metabolic 
bypro ducts throughout the fatigue protocol. 
3.2.0 Hypothesis 
EDL muscles from skMLCK knockout mice will exhibit more fatigue in response 
to repetitive, high frequency stimulation. Low frequency force production will be 
maintained longer in wildtype muscles during the early stage of fatigue. The 
manifestation of fatigue in contractile function will be characterized by the analysis of 
force (Po and Pt), velocity (Vo), rate of force development (+dP/dt) , and shortening-
induced deactivation (SID). The following observations are expected to result from the 
current experiments: 
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1. Myosin light chain kinase (skMLCK) gene ablation is expected to prevent 
phosphorylation of the myosin RLC in KO muscles in response to all type of 
stimulation. Predictably, myosin RLC phosphate content in wildtype EDL muscles 
should increase significantly in response to the repeated muscle activation. 
2. WT muscles are expected to display twitch force potentiation following the 
standard conditioning stimulus and transiently during the early stages of fatigue. This 
contractile phenomenon is not anticipated in skMLCK knockout muscles, an 
observation which would be evident by the expected absence of elevated RLC 
phosphate content. 
3. Repeated tetanic contractions during fatigue protocols are expected to depress 
both peak tetanic force (Po) and twitch force (Pt) in both WT and KO muscles, 
although force potentiation is initially expected to protect twitch force degradation in 
WTmuscles. 
4. High frequency fatigue is expected to be insensitive to the extent of RLC 
phosphorylation, as tetanic contractions represent saturating intracellular [Ca2+]. 
5. Maximal unloaded shortening velocity (Vo) is expected to diminish equally in 
both groups during fatigue, as end product inhibition and muscle activation impede 
maximal crossbridge cycling rate. No significant difference in Vo is anticipated 
between WT and KO muscles, as maximal crossbridge cycling rate should not be 
altered by myosin RLC phosphorylation (Persechini et aI., 1985). 
6. Rate of force development (+dP/dt) is expected to be elevated in wildtype EDL 
muscles, as RLC phosphorylation should increase the rate of crossbridge binding. 
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IV. METHODS 
4.1.0 Wild-Type (WT) & skMLCK Knockout (Ko) Mice 
Two independent strains of C57BLl6 Mice were acquired from the lab of Dr. 
James Stull at the University of Texas Southwestern Medical Center at Dallas (Contract 
ID #800186). The non-dominant coat color allele is spatially associated with the targeted 
gene for myosin light chain kinase knockout, allowing convenient manipulation of coat 
phenotype as a marker for each genetic strain. As such, all wild-type (WT) mice are black 
(homozygous for the recessive non-agouti allele) and all skMLCK knockout (KO) mice 
are agouti (light brown). Disregarding coat color, there were no clear differences in 
phenotypic expression between WT and KO animals- including body mass, total muscle 
length, muscle diameter, and/or absolute peak force-producing capability. 
Mice were sent to the Brock University Animal Facility (Animal Care 
Technician: Dayle Beirne) approximately 2 months after date of birth, where they were 
housed in small groups (1-5) and given free access to standard chow and water until 
required for experimental procedures. All experiments were approved by the Brock 
University Animal Care and Use Committee (Protocol #060102). 
4.2.0 Experimental Apparatus 
All contractile experiments were completed using a custom-designed apparatus 
capable of accurately controlling muscle length and a variety of environmental factors. 
The mouse extensor digitorum longus (EDL) muscle was chosen because it is comprised 
almost entirely of the fast myosin isoforms (63% IIB, 36% IIX, 1% I), that display twitch 
force potentiation and myosin RLC phosphorylation (Crow, M. T., & Kushmerick, M. 1. 
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(1982a, 1982b). Additionally, the mouse EDL muscle is small enough to ensure that most 
fibres remain viable by receiving sufficient oxygen and substrates purely through 
diffusion (Barclay, C.l., 2005). All muscles were suspended in an oxygenated organ bath 
(Radnoti Glass Technology, Inc) containing a physiological salt solution maintained at 
constant temperature using an Isotemp 3013S circulator (Fisher Scientific). Muscle 
stimulation was applied using flanking platinum electrodes driven by a Model 701B 
biphase stimulator (Aurora Scientific, Inc.). Muscle length and diameter was monitored 
separately using a horizontal stereo zoom microscope (Bausch & Lomb. Contractile data 
were collected at 1000Hz from a 305B servomotor acquired through a 604C analog to 
digital interface, and controlled by a dual-mode lever system (ASI). Data acquisition and 
basic analysis was performed using ASI 600a software (Version 1.60) and further 
examined using SigmaStat. 
Figure 7. In vitro mouse EDL model at 25°C. 
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4.3.0 Surgical Removal ofEDL & Muscle Preparation 
Animals were initially sedated with a peritoneal injection of Euthanol diluted 1: 10 
with saline (0.025mg/g body weight). The EDL was carefully excised from each hind 
limb after a non-absorbable braided silk (4-0) suture was fastened to the proximal and 
distal tendons. One EDL was mounted into the experimental apparatus immediately while 
the other was maintained in an oxygenated dissecting medium on ice (see below for 
recipe). Following EDL removal, the animals were euthanized by lethal injection of 
Euthanol into the heart (0.05ml/g body weight) and disposed of according to the 
established Brock University Animal Facility protocol. 
The physiological solution used in all experiments served as a favorable 
environment for muscle contraction and was intended to provide contracting muscle 
tissue with the essential substrates and ions present in vivo. Final ionic concentrations 
were (in mM): 121 NaCI, 5 KCI, 24 NaHC03, 0.4 NaH2P04, 0.5 MgCh, 1.8 CaCh, 5.5 D-
Glucose, and 0.1 EDTA. The solution was continuously gassed (95% 02, 5% CO2) using 
a scintillated glass dispersion valve (Radnoti) and maintained at 25 0 C (± 0.05 0 C). 
4.4.0 Experimental Design 
The isolated EDL in vitro model was used for all experiments to elucidate the role 
of RLC phosphorylation in modulating isometric contractile properties at rest and during 
fatigue. Two identical sets of experiments were conducted on EDL muscles from WT and 
KO mice for analysis of: 1) contractile function, and 2) biochemical quantification of 
muscle metabolites and myosin RLC phosphorylation. 
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Figure 8. Experimental design flow chart. 
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As phosphorylation of the regulatory light chain is a contraction-activated process 
characterized by rapid activation and comparatively slow deactivation, great care was 
taken in controlling the duty cycle and rest intervals during all experiments. Each set of 
contractile experiments involved the quantification of posttetanic potentiation and 
contractile performance during various phases of high frequency fatigue. Contractile data 
was collected from a total of 12-15 muscles from each group (WT and KO) using 
identical experimental procedures. 
The second set of experiments was conducted to fatigue muscles until specific 
reference points (Rest, lmin, 5min), when the EDL was rapidly removed from the bath 
«lOs) and freeze clamped for biochemical analysis. After freezing, each muscle sample 
was split into two equal halves to be analyzed for muscle metabolites (PCr, Cr, ATP, 
ADP, Pi, La-) and myosin RLC phosphorylation. The collective data contained in this 
study therefore represents an analysis of twitch force modulation by posttetanic 
potentiation during resting conditions and a more comprehensive account of contractile 
function and physiological status during various stages of fatigue. 
4.5.0 Force & Length Control Measures 
4.5.1 Muscle Length & Optimal Length (La) 
To normalize all force data, optimal muscle length (Lo) was measured during 
initial force-length measurements (see Preliminary Experimental Procedures). Optimal 
length (Lo) was defined as the length at which peak active twitch force (Pt) was elicited 
and was used as the reference length for all shortening amplitudes. Considerable attention 
was given to the control of muscle length, as the phenomenon of twitch force potentiation 
is highly length-dependent and may be mimicked on the descending limb of the force-
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length curve due to decreased interfilament spacing (Yang et aI., 1998). All experiments 
were therefore conducted at 0.9 Lo and 1.0 Lo to explore the length dependency of force 
potentiation in both wildtype and skMLCK KO muscles. A shorter muscle length was 
expected to abolish this length-dependent force potentiation and magnify the difference 
between wildtype and skMLCK knockout muscles. 
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Figure 9. Example of a force-length relationship in a mouse EDL muscle. Optimal length (Lo) was 
determined as the length at which peak active force was reached. This data was collected from 
one Wildtype EDL muscle during the present study. 
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4.5.2 Determination of Reference Twitch (PJ & Tetanic (Po) Force Values 
Central to the calculation of relative measures such as force potentiation and 
fatigue is the determination of a representative control contraction to serve as a reference. 
In the 60 seconds prior to each potentiation and fatigue protocol, a reference twitch value 
was calculated from the average active force (total tension- resting tension) of at least 
five reference twitches. The initial tetanic contraction of each fatigue protocol was used 
as the reference force (Po) for quantification of high frequency fatigue. These reference 
force values were also used to compare the absolute tetanic and twitch force created in 
WT and KO muscles. 
4.5.3 Twitch Pacing 
It was necessary to continuously monitor contractile function throughout each 
protocol to assess tissue viability. To this end a single muscle twitch was elicited at 
0.05Hz during all periods of quiescence, a method termed twitch pacing. Muscle twitches 
in isolation have negligible influence on RLC phosphorylation (Klug et al. 1982) and 
fatigue, but are included: a) to track the decay of twitch potentiation, and b) as a marker 
for any changes in the physiological state of the EDL preparation (i.e. hypoxia). 
4.6.0 EDL Stimulation 
Five pre-programmed stimuli were used to excite the EDL preparations during all 
contractile experiments. All were applied at supramaximal voltage to ensure that all 
motor units were fully activated. For tetanic contractions, 150Hz stimulation represents a 
supramaximal motor-unit firing rate to ensure completely fused tetani. Stimulation S2 
was used for tetanic contractions during each slack test to allow an adequate force 
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regeneration period following rapid muscle shortening. The conditioning stimulus for the 
potentiation protocol was intended to maximize RLC phosphorylation while 
simultaneously minimizing fatigue. 
4.6.1 Stimulation Profiles 
• S 1. Standard Tetanic Contraction -+ 1000ms at 150Hz 
• S2. Tetanic Contraction [for Slack Test] -+ 1500ms at 150Hz 
• S3. Single Muscle Twitch -+ 1Hz 
• S4. Conditioning Stimulus -+ 150Hz, 400ms, O.2Hz, 20s 
4. 7.0 Mechanical Data Collection 
4.7.1 Peak Force Production 
Peak force was defined as the highest or maximal tension produced in response to 
a given twitch (Pt) or tetanic (Po) stimulation, measured in mN. As the shape of tetanic 
force production varied with changing physiological conditions of the muscle (rest vs. 
fatigue), this analysis did not differentiate at which point during a contraction the peak 
force occurred. 
4.7.2 Maximal Rate of Force Development (+dPldt) 
The relative rate of force development was measured during the first contraction 
of each slack test (Rest, Imin, 5min), before and after a length step of 20% Lo (1.1 Lo to 
0.9 Lo). The initial rise in force was used to compare the maximal rate of force 
development between WT and KO groups, while the rate of force development following 
the 20% Lo was utilized for calculation of SID. These values were determined using the 
ASI 600a software package, which plots a rate function of instantaneous values of +dP/dt 
following smoothing using a Savitsky-Golay Filter. Maximal +dP/dt was calculated as 
the instantaneous rate of force development at the point when tetanic force has reached 
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20% of maXImum force. This approach was chosen as an objective method for 
quantifying a relative +dP/dt value, permitting effective comparison between muscles and 
to eliminate highly variable absolute values. 
4.7.3 Slack Test for Maximal Unloaded Shortening Velocity (Va) 
The Slack Test (Edman, 1979) was used as an indicator of the maximally capacity 
to shorten the contractile apparatus during rest and fatigue conditions. Slack was briefly 
produced in the EDL preparation by rapidly shortening muscle length to a pre-determined 
position during a fused tetanic contraction. The time required for a contracting EDL to 
actively take up the compliance (slack) and produce measurable force was termed the 
slack time. It has been shown (Edman, 1979) that the size of the length step is positively 
correlated with slack time in a robust linear relationship (see below). 
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Figure 10. Force redevelopment traces of 4 tetanic contractions during the slack test to illustrate 
the positive correlation between step size and slack time. 
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Given that step size (% Lo) is a quantifiable distance (mm) and slack time (ms) is 
a measure of time, the slope of the linear regression represents a velocity (distance/time). 
Therefore at each time point, for each individual muscle, the appropriate step sizes were 
graphed against slack time to obtain measures of Vo and were pooled within group to 
create mean Vo values. Five length steps were applied during sequential tetanic 
contractions (10, 12.5, 15. 17.5. 20 % Lo) to create a strong linear relationship (:::::0.99). 
Slack time was determined using a calculation-based method due to the difficult nature of 
discerning the exact moment of force redevelopment. This calculation involved 
differentiation of the force-time function and subsequent quantification of 20% of the 
peak rate of force development (+dP/dt). The time that corresponded to 20% of peak 
+dP/dt was subtracted from the time at which the length step was initiated to calculate 
slack time (see below). 
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Figure 11. Example plot for quantification of maximal unloaded shortening velocity (Va). Mean 
slack times from the current study (n=10) were graphed against the five shortening steps used 
during the slack test (10, 12.5, 15, 17.5, and 20%La). Throughout fatigue, muscles exhibited 
significantly larger slack times for a given step size, effectively decreasing the slope of the linear 
regression. The slope of each line was used to calculate Va at each time point, as it represents a 
distance (%La) divided by time (s) (i.e., velocity = distance/time). 
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The slack test was manipulated to control for the opposing processes of fatigue 
and recovery, to ensure that the physiological status of the muscle remained relatively 
stable across each of the five sequential tetanic contractions. This was accomplished by 
varying the rest period between each successive contraction. This rest period was 
intended to stabilize the status of high frequency fatigue in the EDL (% Po), while 
presenting a duty cycle that would limit the extent of force recovery between 
contractions. The slack test was initially applied during a quiescent period (Rest), 
following 60-seconds of fatiguing contractions (lmin fatigue), and in the fatigued state 
following the full five minutes of repetitive stimulation (5min fatigue). Slack test data 
was collected from a total of 20 EDL muscles (10 WT, 10 KO) and provides a clear 
indication of whether myosin RLC phosphorylation influences how fast the actual 
molecular machinery (myosin crossbridge) can cycle along the thin filament against zero 
extemalload (slack). 
4.7.4 Shortening-Induced Deactivation (SID) 
Shortening-induced deactivation (SID) was quantified in WT and KO muscles 
during the first contraction of each slack test (Rest, lmin, 5min). The rapid length step 
(20% Lo) was applied once the muscle had reached maximal isometric force. A ratio was 
calculated using the rate of force development measurements taken during the initial rise 
in force and following the 20% Lo length step during force redevelopment. 
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[ +dPldt Post-length step] I [+dPldt Pre-length step] = SID 
The 20% Lo length step was chosen for analysis of SID for two reasons: 
• The 20% Lo length step was the largest length step implemented during the slack test 
protocol. As SID has been shown to increase as the magnitude of shortening increases, 
this was assumed to magnify a potential difference between groups (should one exist). 
• Comparison of +dP/dt before and after a length step may be problematic because 
myofilament overlap at the shortened length could change significantly, thus 
influencing the results. The 20% Lo length step was initialized at 1.1 Lo and reduced 
muscle length to 0.9 Lo. As both pre and post length step values are approximately 
equidistant from optimal length (~O.l Lo), this length step was assumed to minimize 
the significance of force-length variations. 
4.8.0 Contractile Experiments 
4.8.1 Laboratory Procedures 
Prior to a standard 20-minute equilibration period, the EDL was stimulated 
(150Hz, 1000ms) to produce a contraction forceful enough to remove any compliance 
and possible slippage of the tendon-suture unions. Subsequently, a single twitch was 
applied at 0.05Hz while sequentially increasing current intensity until a maximum twitch 
force was reached. The stimulus intensity was then increased ~25% and remained at this 
magnitude for the duration of each experiment to ensure maximal excitation of all motor 
units. Following the equilibration period, the optimal length (Lo) was determined. 
Initially, Lo was estimated by stretching the muscle to 10mN of passive tension; a value 
that generally corresponded to peak active force production in previous experiments. 
This initial muscle length became the temporary Lo for the optimal length protocol. From 
~0.7Lo the muscle was lengthened at 0.02 Lo increments while being stimulated at each 
length. The muscle length at which active twitch force reached a maximum was 
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documented as Lo and used as the reference length for all subsequent length steps. The 
accuracy of all length changes and positions was corroborated manually using a stereo 
zoom microscope (Bausch & Lomb) to provide measurements of muscle length (mm). 
Following these standard preliminary procedures, a contractile experiment was 
conducted. Each experiment was officially terminated when the EDL was rapidly frozen 
in liquid nitrogen and stored at -800 C for future biochemical analysis. Prior to the 
mounting of each fresh EDL muscle, the Tyrode solution was replaced with a fresh 
aliquot and given sufficient time to equilibrate (~I5min). 
4.8.2 Quantifying Posttetanic Potentiation (PTP) 
The PTP protocol was designed to examine the hypothesis that only EDL muscles 
from WT mice would exhibit potentiated twitch force in response to a conditioning 
stimulus (vs. EDL muscles from skMLCK KO). Each muscle was tested for force 
potentiation at 2 muscle lengths (Lo and 0.9 Lo) to explore the expected length-
dependency of force potentiation. After collecting a reference twitch value at each length 
(Lo and 0.9 Lo) and applying the standard conditioning stimulus, twitch force was 
measured at 9,11, 13, 17, 19 and 2I-seconds (following cessation of the conditioning 
stimulus). Muscle length was shortened from Lo to 0.9 Lo I5-seconds following the 
conditioning stimulus, ensuring that three twitches were available for analysis at each 
muscle length. The order of length changes within the protocol was reversed for at least 
five muscles per group to remove a potential order effect, where measured PTP would be 
insensitive to the process of lengthening and shortening. The twitches collected before 
and after the length change were designed to be equidistant to the I5-second time point-
the instant at which pilot experiments exhibited maximal twitch potentiation. 
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4.8.3 High Frequency Fatigue and Unloaded Shortening Velocity 
The objective of these experiments was to collect a variety of contractile data 
during a fatigue protocol. Slack Tests were conducted before; during, and following a 5-
minute fatigue protocol to measure unloaded shortening velocity (Vo) in a variety of 
physiological conditions (rest, moderate fatigue, severe fatigue). Muscle length remained 
constant throughout the standard fatigue protocol, at 0.9 Lo. During each period of 
fatiguing contractions the EDL muscle received one tetanic (S 1) and one twitch (S3) 
stimulus every 5 seconds (O.2Hz). At the conclusion of each contractile experiment, the 
protocol was terminated by rapidly freeze-clamping the muscle with pre-cooled pliers. 
Muscles samples were then stored at -800 C until biochemical analysis. Figure 12 
illustrates the time line and design of all experimental protocols. 
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Figure 12. Schematic of contractile experiments. Separate groups of muscles were frozen prior to 
(Rest), during (1 Min), & following (5Min) repetitive stimulation. 
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4.9.0 Biochemical Analysis of Muscle Tissue 
4.9.1 QuantifYing Metabolic Conditions During Fatigue 
The purpose of the second set of experiments was to freeze muscles at specific 
time points for quantification of muscle metabolites. Measurement of metabolic 
byproducts during fatigue was intended to establish the relative cost (or benefit) of 
myosin RLC phosphorylation during repetitive stimulation. The procedure of the 
contractile experiments was precisely replicated until premature termination by rapid 
freezing of the EDL (parallel incubations). Muscles were frozen prior to any fatiguing 
contractions (Rest), following Imin of fatigue (moderate fatigue), and following all 
contractile protocols. 
The variability of data associated with running metabolic assays with very small 
muscle samples (Slmg. dry weighrl) is inescapably high. It was necessary, therefore, to 
pool muscle samples to improve the reliability of the data. In these cases, freeze-dried 
muscle tissue was combined from two samples (matched for group and time point) during 
the extraction procedure. This method increased the mass of muscle sample available for 
extraction and was utilized to remove some of the experimental error associated with 
weighing and extracting the muscles. 
Three specific assays were used to identify the relative concentration of the 
metabolites of interest (ATP-PCr, Cr, La-). Concentrations of ADP and inorganic 
phosphate (PD were calculated from known Keq values and delta-PCr, respectively. Raw 
metabolite concentrations were normalized for mean total creatine content. For detailed 
procedures of muscle extraction, metabolite assays, and calculation for ADP and 
inorganic phosphate (Pi) please refer to appendix 2 and 3. 
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4.9.2 Myosin RLC Phosphorylation 
Mouse EDL muscles were frozen prior to, during, and following 5-minutes of 
repetitive stimulation. Myosin RLC phosphate content was quantified using 2 
dimensional-isoelectric focusing. Muscle samples were -4-6mg (dry weight). 
4.10.0 Data Analysis & Statistics 
The central intervention investigated was the effect of skMLCK KO on 
contractile performance at rest and during fatigue. Measurement of muscle metabolites 
and myosin RLC phosphorylation provided additional data to compare WT and KO 
muscle performance at rest and during fatigue. To determine the effect of skMLCK 
knockout (WT vs. KO) and treatment (i.e., time, length), a significant difference between 
means was determined using a two-way ANOVA. For the analysis of contractile data, a 
repeated measures ANOV A was used. Metabolic analysis was completed with a standard 
two-way ANOV A, as each muscle sample was assayed only once for a given metabolite. 
Given a significant interaction between group and treatment, Post-hoc analysis 
was completed using Tukey's HSD test. All data are presented as the sampled mean +/-
SEM. For comparison of mean mouse age and absolute force production, a two-tailed 
Student's t-test was performed. 
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V.RESULTS 
5.1.0 Myosin RLC Phosphorylation 
Myosin RLC phosphate content was quantified as the proportion of RLC 
molecules in the phosphorylated state versus total myoSIn (P-skRLC/Total skRLC). 
Muscles from KO mice exhibited low myosin RLC phosphorylation at rest, and were not 
influenced by repetitive stimulation for the duration of the fatigue protocol (see Table 1). 
WT myosin RLC phosphorylation was significantly higher at all time points when 
compared to KO muscles (p<O.OOl). Myosin RLC phosphate content increased 
significantly during the first minute of the fatigue protocol, rapidly reaching maximal 
phosphorylation (0.63 ± 0.03). The remaining 4 minutes of repetitive stimulation did not 
significantly influence myosin RLC phosphorylation, although the myosin RLC was 
phosphorylated to a lesser degree at 5-minutes (0.57± 0.02 P-skRLC/Total-skRLC). 
Group 
\¥T 
KG 
Rest 
0.39± 0.05 * 
0.08 0.02 
1min 
0.63± 0.03 *t 
0.07 + 0.01 
5min 
0.57 :;:t *t 
0.07± 0.02 
Table 1. Summary of myosin RLC phosphate content in WT and KO muscles prior to, during and 
following 5-minutes of fatiguing contractions (n=5-8). Myosin RLC phosphorylation is quantified 
as the ratio of phosphorylated myosin to total myosin content (P-skRLC/Total-skRLC). (*) 
Significant difference between groups (within time point, p<O.001). (t) Significant difference from 
Rest value (within group analysis, p<O.001). 
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5.2.0 Mouse Characteristics 
No significant difference was found between WT and KO groups for mean mouse 
age, peak tetanic force (Po), or peak twitch force (P t) in the contractile experiments. The 
mean age of WT mice used in the biochemical analysis experiments was significantly 
lower than mean KO mouse age (92.5 ± 1.1 vs. 152.0 ± 5.5 days). In addition, the mice 
used in the contractile experiments were significantly older than those used for the 
muscle freezing experiments (p<O.OI). It is unclear whether this average difference in age 
(~160 days) would influence contractile performance or muscle phenotypic expression. 
F or the present discussion, it is assumed that age did not influence the structure or 
function of the EDL muscles enough to significantly alter myosin RLC phosphorylation 
or metabolic accumulation. 
Absolute (mN) and Relative (mN/mm) Baseline Force Values 
Group 
Tetanic Force (Po) 'TWItch Force (Pt) 
Absolute Normalized Absolute Normalized 
WT 2f192 ± 40.5 122.9 ± 16.7 56.1 ± 12.7 22A± 4.1 
KO 302.3 ± 29.5 122.5 ± ILl{ 40.6 ± 4.9 17.8 ± 22 
Mean Mouse Age (days) 
Group Contractile Experiments . Biochemical Analysis Experiments 
WT .9 ± 36.5 92.5 ± 1.1 
* KO 3023 ± 29.5 152.9 ± 5.5 
Table 2. Mean mouse age and baseline force values for individual muscles used in the contractile 
experiments (n=12) and mean age for muscles frozen for biochemical analysis (n=20-24). Data 
are presented as mean ± SEM. (*) Significant difference between mean age of WT vs. KO mice 
in biochemical analysis experiments (Student's t-test, p<O.05). Force is normalized to muscle 
diameter (mm), which was measured at Lo prior to each contractile experiment using a stereo 
zoom microscope. This is not a true evaluation of muscle specific force, as cross-sectional area 
was not measured. 
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5.3.0 Posttetanic Potentiation (PTP) & Muscle Length 
Analysis of posttetanic potentiation (PTP) established a main effect for muscle 
length (0.9 Lo vs. 1.0 Lo) and group (WT vs. KO), and a significant positive interaction 
between group and treatment (p<O.OOl). KO muscles did not exhibit any force 
potentiation, as mean PTP was 2.5 ± 0.02% and 1.2 ± 0.02% for 1.0 Lo and 0.9 Lo, 
respectively. WT muscles potentiated significantly more at both 0.9 Lo than 1.0 Lo 
(p<O.OOl). Twitch force in WT muscles was potentiated 37.2 ± 0.04% at 0.9 Lo and 12.5 
± 0.01 % at 1.0 Lo. 
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Figure 13. The effect of length on Posttetanic Potentiation (PTP) at rest (n=15). (*) Significant 
difference between groups within a given muscle length (p<O.001). (t) Significant effect of length 
on PTP in WT muscles (within group analysis, p<O.001). 
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5.4.0 Twitch (PJ & Tetanic (Po) Force Production During Fatigue 
5.4.1 Low Frequency Force Modulation 
Low frequency force production was measured every 5-seconds throughout the 5-
minute fatigue protocol (Figure 14). Statistical comparison between WT and KO twitch 
force was completed only for the first minute of the fatigue protocol. The relative 
difference in Pt between WT and KO muscles during the remainder of the fatigue 
protocol (l-5minutes) was clearly minimal and was therefore excluded from statistical 
analysis so as not to obscure the acute group and time interaction (0-35 seconds). 
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Figure 14. Relative twitch force (PI) during fatigue (n=12). The fatigue protocol was suspended 
from 60s until 135s for measurement of unloaded shortening velocity (n=12). (*) Significant 
difference in relative twitch force between groups. (t) WT twitch force potentiated above baseline 
twitch force. (tt) KO twitch force potentiated above baseline twitch force. 
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The analysis of twitch forces during fatigue yielded a significant main effect for 
group and time (p=0.02 and p<O.OOl) and a significant interaction between group and 
time (p<O.OOI). The five minutes of repetitive stimulation reduced twitch force to ~75% 
in both WT and KO muscles. WT muscles exhibited significantly greater twitch force 
than KO muscles during the first 35-seconds of the fatigue protocol. Interestingly, both 
WT and KO muscles exhibited significant force potentiation above the reference twitch 
(although to a different extent). Within group analysis revealed that WT twitch force was 
significantly potentiated above the reference twitch value for the first 30-seconds of the 
fatigue protocol, peaking at I5-seconds (37.2 ± 0.05%). Alternatively, KO twitch force 
was significantly potentiated above the reference twitch value for a brief time (10-20 
seconds of the fatigue protocol). KO twitch force potentiation also peaked at I5-seconds 
at 14.3 ± 0.02%. There was no significant difference in twitch force between groups for 
the 1-5 minute component of the fatigue protocol. 
5.4.2 High Frequency Fatigue 
Five minutes of repetitive, high frequency stimulation depressed maximal tetanic 
force production in WT and KO muscles equally. There was no significant difference in 
relative tetanic force (% initial) between WT and KO muscles during any individual time 
point, despite very low within-group variability (SEM). Statistical analysis produced a 
main effect for time (p<O.OOl), as mean tetanic force production declined ~90% in both 
WT and KO muscles. The largest proportion of this force degradation occurred during the 
first minute of stimulation as tetanic forces declined to ~40% of initial. 
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Figure 15. Tetanic force (Po) degradation during 5-minutes of repetitive stimulation. The fatigue 
protocol was paused from 60s until 135s for measurement of unloaded shortening velocity (Va) 
(n=12). Both WT and KO muscles were slightly more fatigued after the measurement of Va at 1-
minute (:::7%), although this effect was not different between groups. 
5.5.0 Maximal Unloaded Shortening Velocity (Vo) 
The intrinsic capacity to shorten the contractile apparatus (slack test) was assessed 
prior to (Rest), during (1min), and following (5min) the 5-minute fatigue protocol (Figure 
16 & 17). WT muscles exhibited a slightly higher absolute Vo value at all time points, 
although the difference between means was not statistically significant (p=0.304). There 
was a significant main effect for time as Vo decreased significantly during the fatigue 
protocol (p<O.OOI). Repetitive stimulation depressed shortening velocity ~20% within the 
first minute and a further 15% during the remaining period of fatiguing contractions (1-5 
minutes). WT shortening velocity decreased from 14.96 ± 0.78 fibre lengths/s (Rest) to 
11.56 ± 0.59 at I-minute, further degrading to 9.60 ± 0.57 at the cessation of the fatigue 
protocol. Analysis of KO muscles demonstrated that resting Vo (13.95 ± 1.07) was 
reduced to 10.53 ± 0.62 at I-minute before diminishing to 8.39 ± 0.36 at 5-minutes. 
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The relative degradation of shortening velocity during fatigue was compared 
between groups, although no significant group effects were found when WT and KO 
means were compared (Figure 18). As with the absolute Vo values, the relative 
degradation of shortening velocity demonstrated a significant main effect for time 
(p<O.OO 1). Both absolute and relative comparisons demonstrated that the majority of the 
degradation of Vo occurred during the first minute of repetitive stimulation. This was 
evident from the absence of a significant difference between I min and 5min time points 
for absolute and relative pooled means. 
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Figure 16. Maximal Unloaded Shortening Velocity (Va) during fatigue (n=9-10). (t) Significant 
difference in absolute Va compared to Rest. 
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5.6.0 Rate of Force Development (+dPldt) 
Rate of force development was assessed during the first contraction of each slack 
test (Rest, Imin, 5min). The +dP/dt value was objectively calculated as the instantaneous 
rate of force development when the muscle had developed 20% of peak tetanic force (see 
methods section 4.7.2 for details). Three measures of +dP/dt were analyzed in the present 
project. First, peak +dP/dt during the initial rise of force during a tetanic contraction was 
quantified (Figure 18). Second, the +dP/dt during force redevelopment was calculated 
following a 20% Lo length step (at the midpoint of the same contraction). These values 
were also used for the calculation of shortening-induced deactivation (see Figure 21 & 
22). Finally, peak +dP/dt values were used to calculate the relative degradation of force 
development during fatigue (Figure 20). Analysis of peak +dP/dt revealed a main effect 
for time (p<O.OOl) and group (p<O.OOl), and a significant genotype vs. time interaction 
(p<O.OOI). Peak +dP/dt at Rest was almost twice as high in WT muscles when compared 
67 
to KO muscles (5490 ± 573 vs. 2920 ± 208 mN/s). Although absolute +dP/dt decreased 
significantly with time, the difference between groups remained proportionally the same 
at I-minute (4349 ± 461 vs. 2311 ± 270) and 5min (2255 ± 256 vs. 1171 ± 120). Rate of 
force development (+dP/dt) after shortening was statistically equal in WT and KO 
muscles, although a significant main effect for time was produced (p<O.OOI). The relative 
degradation of +dP/dt during fatigue was similar in both WT and KO (no significant 
main effect for group). WT and KO muscles demonstrated a ~20% decline in +dP/dt at 1-
minute and a further 40% decline during the remainder of the fatigue protocol (1-5 
minutes). These differences produced a significant main effect for time (p<O.OOI), as all 
pairwise comparisons were significant (Rest vs. Imin, Imin. vs. 5min, Rest vs. 5min). 
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Figure 18. Peak rate of force development (+dP/dt) during the initial rise in force during the 20% 
Lo length step of each slack test (n=9-10).(*) significant difference between groups at each time 
point (p<0.001). (t) Significant difference from Rest +dP/dt (within group analysis, p<0.001). 
(tt). Significant difference from 1min +dP/dt (within group analysis, p<0.001). These values were 
normalized by finding the instantaneous +dP/dt value measured at 20% of peak force production 
(see section 4.7.2). 
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Figure 19. Rate of force development (+dP/dt) following a 20% Lo length step (n=9-10). (t) 
Significant difference from Rest +dP/dt (p<0.001). (tt) Significant difference from 1min +dP/dt 
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Figure 20. Relative degradation of +dP/dt during fatigue (n=9-10). (t) Significant difference from 
Rest (p<0.001). (tt) Significant difference from 1 min (p<0.001). 
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5.7.0 Shortening-Induced Deactivation (SID) 
Shortening-induced deactivation (SID) measured the effect of a 20% Lo length 
step on subsequent rate of force development. Rapid shortening during a maximal tetanic 
contraction in vivo is thought to deactivate the thin filament to a substantial degree such 
that +dP/dt is attenuated as force is redeveloped. For each muscle, a ratio was created 
from the +dP/dt values measured before and after the 20% Lo length step. These values 
were pooled within group and time point for statistical comparison of means (Figure 21). 
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Figure 21. Shortening-induced Deactivation during fatigue (n=9-10). (*) Significant difference 
between groups at each time point (p<O.05), (t) Significant difference from Rest +dP/dt (within 
group analysis, p<0.001). (tt) Significant difference from 1 min +dP/dt (within group analysis, 
p<O.05). 
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Statistical analysis established a significant main effect for group (p<O.OOI) and 
time (p<O.OOI), and a significant genotype vs. time interaction (p=0.024). SID was 
significantly greater in WT muscles at Rest and I-minute (Figure 21), however, this 
difference was not observed in the 5-minute values. SID was 1.39 ± 0.02 for KO muscles 
at rest, demonstrating that higher +dP/dt was observed after rather than prior to active 
shortening. The net effect of repetitive stimulation on SID was depressive, as +dP/dt 
following the length step (Figure 19) diminished more rapidly than peak +dP/dt (Figure 
18). The degradation of SID was statistically similar in both WT and KO muscles. 
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Figure 22. Degradation of SID during fatigue (n=9-10). (t) Significant difference between Rest 
and 1 min (p<0.001). (tt) Significant difference between 1 min and 5min (p<0.001). 
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5.8.0 Biochemical Analysis 
5.8.1 Muscle Metabolites 
Muscle metabolite concentrations were found to be statistically similar in WT and 
KO muscles (Figure 24), as there was no significant group interaction found in the 
analysis of ATP, ADP, Pi, PCr, Cr, or La-. In each case, however, there was a significant 
main effect for time (p<O.05) as repetitive stimulation altered the concentration of each 
metabolite from resting values within the first minute of stimulation. 
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Figure 23. Muscle metabolites during fatigue (n=2-5). (t) Significantly different metabolite 
concentration compared to Rest (p<O.05). 
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A trend emerged in the metabolite data from the I-minute time point to 5-minutes. 
WT muscles exhibited a small but consistent metabolic improvement in the remainder of 
the fatigue protocol, such that [PCr] increased while Cr, La-, ADP and Pi concentrations 
decreased. This trend was in stark contrast to that of KO muscles, which displayed a 
decrease in [PCr] and increased [Cr], [La-], and [Pi]. The concentration of ATP was 
depressed to a larger extent in WT muscles at 5-minutes, although this difference was not 
significant (19.3±1.3 vs. 25.5±3.5 mmol/kg.dry wr1). Similarly, the concentration of 
ADP was lower at 5-minutes in WT muscles, although the absence of a significant group 
effect and significant interaction did not allow this individual statistical comparison. 
Inorganic Phosphate (mmolikg.dry wr') ADP (IJmollkg.dry wr') 
Group 
Rest , 1min 5min Rest 1min 5min 
WT 2.30 48.4t 44.8t 67.2 ± 21 207.2 ± 7t 158.1 ± 32t 
...... 
KO 230 46.2t 60.1 t 57.4 ± 9 , 211,6± 28t 203.3 ± 11 t 
Table 3. Concentrations of inorganic phosphate (Pi) and ADPfree during fatigue in WT and KO 
muscles (n=2-5). (t) Significant difference from Rest value (p<O.05). For detailed explanations of 
the calculations involved, please refer to the appendixes. 
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5.9.0 Summary a/Findings & Statistics 
The important parameters of contractile performance studied in this project did 
not respond similarly to repetitive stimulation. It is clear that individual contractile 
parameters have different sensitivities to fatigue. Moreover, the percentage of fatigue that 
occurred during the first minute of stimulation was variable from measure to measure-
suggesting that intrinsic contractile properties are differentially influenced by various 
environmental factors. Tables 4 and 5 summarize the most important findings observed in 
this study, including statistical analysis where applicable. Independent of muscle 
genotype, the ability to produce maximal force (Po) was the most susceptible to repetitive 
stimulation, fatiguing ~90% during the 5-minute protocol (71 % during the first minute). 
Unloaded shortening velocity (Vo) degraded the least during fatigue (declining only 
36%). Tetanic force and shortening velocity were especially susceptible to fatigue within 
the first minute. 
Measure Group 
Fatigue (tmin) Fatigue (Smin) % of Total Fatigue 
% "/ .. D-lmin l-Smin 
WI' 28 67 42% 58% 
Twitch Force (P,) 
34 48% KO 71 52% 
WT 64 90 71% 29% 
Peak Tetanic Force (P~) 
KO 64 91 70% 30% 
WI' 23 33 70% 30% 
Unloaded Shortening ~Iocity (Vo ) 
KO 25 40 63% 38% 
'WT 19 58 33% 67% 
Rate of Force Development (+dP/dt) 
KO 20 59 34% 66% 
Table 4. Summary of the relative fatigue associated with each contractile measure, including the 
proportion of fatigue that occurred during the acute (O-1min) and subacute (1-5min) segments of 
the experiments. 
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VI. DISCUSSION 
6.1.0 Coincident Myosin RLC Phosphorylation & Fatigue 
The present results illustrate that the elimination of myosin RLC phosphorylation 
by skMLCK KO does not significantly influence maximal force production (Po), 
shortening velocity (Vo), or the accumulation of metabolic bypro ducts during fatigue. In 
addition, there is no evidence that the presence of elevated myosin RLC phosphate 
content significantly intensifies any of the measured markers of fatigue. The following 
discussion explores these concepts to justify the central finding that myosin RLC 
phosphorylation maintains the contractile performance of WT muscles during fatigue 
with no associated metabolic cost. Investigation of the single muscle twitch and the 
kinetics of force development has substantiated the previous findings that myosin RLC 
phosphorylation is an important modulator of crossbridge attachment during contraction 
and is the primary mechanism of force potentiation in skeletal muscle. The observation 
that muscle twitch force is transiently maintained in WT muscles in the presence of 
considerable fatigue agrees with the present hypothesis that myosin RLC phosphorylation 
initially preserves the mechanical function of skeletal muscle during repetitive high 
frequency stimulation. The similar reduction of +dP/dt in KO muscles throughout the 
fatigue protocol provides evidence that the mechanical benefit of myosin RLC 
phosphorylation persists independent of muscular fatigue. Finally, metabolic analysis 
highlighted that while the accumulation of specific metabolites was not statistically 
different between WT and KO muscles, it seems likely that the elevated metabolic cost of 
myosin RLC phosphorylation early in fatigue may be offset by more energy efficient 
crossbridge cycling in the phosphorylated state. 
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6.2.0 Contractile Mechanics 
6.2.1 Force Modulation: Potentiation & Fatigue 
Posttetanic Potentiation (PTP) following a brief conditioning stimulus was 
eliminated in skMLCK knockout muscles. Myosin RLC phosphate content was not 
measured before and after the conditioning stimulus. However, the current conditioning 
stimulus (four 150Hz, 400ms stimuli) was similar to that used previously (150Hz, 2s) to 
elicit a significant elevation of myosin RLC phosphate content in WT muscles (Zhi et al. 
2005). The observation of significant PTP in WT muscles and the absence of PTP in KO 
muscles confirms the hypothesis that myosin RLC phosphorylation is the mechanistic 
basis of twitch force potentiation in rested skeletal muscle following brief, high intensity 
activation. The additional observation that PTP is length-dependent in WT muscles 
suggests that the beneficial spatial alteration of myosin crossbridges in the 
phosphorylated state is more important at short muscle lengths where interfilament 
spacing is significantly greater (Yang et al. 1998). Muscle length is therefore a critical 
consideration in future studies aiming to observe force potentiation and the influence of 
myosin RLC phosphorylation on contractile performance in all experimental models (in 
vitro, in situ, in vivo). 
The finding that skMLCK KO does not eliminate twitch force potentiation during 
repetitive, intermittent stimulation implies that an additional mechanism is present which 
produces the same effect as myosin RLC phosphorylation. The most likely explanation is 
that myoplasmic [Ca2+], in the absence of stimulation, was not stable throughout the 
fatigue protocol. Specifically, if the concentration of Ca2+ within the muscle remained 
transiently elevated following each tetanic contraction, the resulting twitch force would 
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be potentiated (as seen during the early stages of fatigue). This possibility has been 
discussed by Allen et al. (2008b), who suggest that rapidly increasing Pi during fatigue 
may inhibit SR Ca2+ pumping. As Ca2+ is actively pumped into the SR against its 
concentration gradient, any factor that could reduce the affinity for ATP hydrolysis 
would theoretically reduce the rate and efficiency of Ca2+ reuptake. This mechanism 
could explain why skMLCK KO muscles selectively exhibit force potentiation during 
repetitive intermittent stimulation and not following a brief, isolated conditioning 
stimulus. Although the current study did not measure calcium during the fatigue protocol, 
the perturbation to calcium handling that may have occurred in the skMLCK KO muscles 
is likely to have occurred in the WT muscles as well, as both displayed similar [Pi]. 
Future studies should incorporate the measurement of intracellular calcium during fatigue 
to corroborate this theory. 
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Figure 24. The difference in twitch force between WT and KO muscles during fatigue. Each point 
in figure 25 was calculated from the difference in relative twitch force between WT and KO 
muscles at a given time point. Myosin RLC phosphorylation itself potentiated twitch force -23% 
within the initial i5-seconds of stimulation and continued to protect twitch force for the remainder 
of the fatigue protocol (although this difference was not statistically significant after 35-seconds). 
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Assuming that the SR Ca2+ pump was also inhibited in WT muscles, the relative 
role of myosin RLC phosphorylation in potentiation of twitch force during fatigue was 
calculated as the difference between peak potentiation in WT muscles (37.2 ± 0.05%) and 
peak potentiation in KO muscles (14.3 ± 0.02%). Therefore, myosin RLC 
phosphorylation itself potentiated twitch force by approximately 23%, accounting for 
approximately 62% of total twitch force potentiation. Figure 24 tracks the difference in 
relative twitch force (% initial) between WT and KO muscles to highlight the beneficial 
effect of myosin RLC phosphorylation above and beyond the mechanism that potentiated 
KO twitch force (i.e. possible Ca2+ effects). 
6.2.2 Maximal Force Production: Peak Tetanic Force (Po) 
The absence of skMLCK and the resulting absence of elevated myosin RLC 
phosphate content was not expected to influence peak tetanic force production because 
the Ca2+ -sensitizing effect of myosin RLC phosphorylation is of limited importance at 
saturating [Ca2+] (Persechini et al. 1985). Accordingly, both WT and KO muscles 
exhibited similar high frequency fatigue profiles. Peak tetanic force was depressed ~90% 
in both groups over the 5-minute period of repetitive high frequency stimulation. The 
mechanisms of force depression during fatigue were assumed to be similar in WT and 
KO muscles, as decreased Ca2+ release during contraction and decreased sensitivity to 
Ca2+ (due to end-product inhibition) limit the quantity and quality of force-producing 
actin-myosin interactions. Calcium measurements were not obtained during the 
experiments to quantify the influence of altered Ca2+ -handling on force production. 
However, metabolite data demonstrate that the most effective inhibitor of force 
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production, inorganic phosphate, was significantly elevated in both WT and KO muscles. 
In conclusion, the current experiments establish that skMLCK KO has no significant 
effect on the maximal force produced in response to I-second high frequency tetanic 
contractions in vitro. 
6.2.3 Crossbridge Cycling Rate: Velocity o/Shortening (Va) 
Crossbridge cycling rate governs the velocity at which skeletal muscle can 
shorten in response to zero external load (Edman, 1975). As hypothesized, WT and KO 
muscles produced statistically similar values of unloaded shortening velocity at rest, 
during and after fatigue. In addition, the relative degradation of Vo during fatigue was 
statistically similar in both WT and KO groups. 
Perhaps the most important predictor of shortening velocity is the predominant 
myosin isoform present. Fast myosin isoforms (IIA<IIX<IIB) catalyze the hydrolysis of 
ATP at a greater rate than type I fibres and therefore exhibit higher rates of crossbridge 
cycling and A TP turnover. Muscle fibre type was not controlled for in the present study; 
however, there is some evidence to suggest that both WT and KO muscles expressed 
similar myosin phenotypes. Both groups produced similar maximal force levels at rest. 
There was no visual evidence to suggest that muscle diameter was significantly different 
between WT and KO muscles during any of the experiments (as assessed visually with 
the stereo zoom microscope). It can be assumed, therefore, that if KO muscles had 
expressed significantly more or less type II fibres than WT muscles, that average 
differences in muscle specific force would have influenced this measure. Furthermore, 
mean mouse age was not different in the contractile experiments, reducing the possibility 
that age-induced fibre type shifts could influence the comparison. Additional evidence 
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can be found in the fatigue profiles of WT and KO muscles. Both groups fatigued almost 
identically throughout five minutes of repetitive stimulation. It seems likely that a 
significant difference in fibre type would have manifested itself in altered rates of fatigue 
due to the different metabolic capacity associated with a change in myosin isoform 
expressIOn. 
The rate-limiting step of the crossbridge cycle during muscle contraction is the 
release of ADP, which facilitates the binding of a new ATP molecule to the myosin head 
and catalyzes crossbridge detachment from the thin filament (Chase & Kushmerick, 
1995; Cooke & Pate, 1985). The results of metabolic analysis did not produce any 
statistical difference in [ADP] between WT and KO muscles. This outcome is in 
agreement with the contractile data described above, as no difference in Vo was observed 
between WT and KO muscles. 
In conclusion, the ablation of skMLCK does not seem to significantly influence 
the maximal unloaded shortening velocity in isolated mouse skeletal muscle. This finding 
supports previous reports that unloaded shortening velocity is insensitive to myosin RLC 
phosphorylation, and refutes more recent evidence that myosin RLC phosphorylation 
contributes to the reduction of unloaded shortening velocity during conditions that mimic 
fatigue (Karatzaferi et aI., 2008). The discrepancy in these conclusions may lie in subtle 
differences inherent to the individual models of study. The current experiments were 
completed on whole muscles in vitro at 25°C, while those reporting the opposite findings 
were completed at 30°C on isolated skinned muscle fibres with chemically induced 
myosin RLC phosphorylation (Karatzaferi et aI., 2008; Franks-Skiba et aI., 2007). It is 
possible that the effect of myosin RLC phosphorylation on shortening velocity may be 
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different at temperatures that approach physiological temperatures; however, the current 
results demonstrate that this modulatory mechanism does not influence maximal 
shortening velocity in whole muscles in vitro at 25°C (as measured using the slack test). 
6.2.4 Rate of Force Development (+dP/dt) & Shortening-induced Deactivation (SID) 
The present finding that skMLCK knockout significantly impairs rate of force 
development is in agreement with the theory that myosin crossbridges in the 
phosphorylated state bind more rapidly and effectively with actin during muscle 
activation. When measured during the initial rise in force of a fully fused tetanic 
contraction, KO muscles exhibited only half the mean +dP/dt when compared to WT 
muscles at all stages of fatigue. This finding has significant implications for the 
contractile performance of skeletal muscles in vivo. The fact that +dP/dt is augmented 
during high frequency stimulation provides evidence that peak force production for 
contractions of shorter duration may be considerably improved in the presence of myosin 
RLC phosphorylation. 
The traces shown in Figure 25 suggest that ablation of skMLCK may attenuate 
the peak force produced during fused tetanic contractions lasting less than ~300ms. This 
effect may be highly significant for patterns of brief, repetitive muscle activation found 
during various movements and locomotion, as peak force produced during a brief 
contraction may be sensitive to high rates of force development. 
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Figure 25. Force-time traces of WT and KO muscfes during a fully fused tetanic contraction at 
25°C. The ablation of skMLCK attenuated +dP/dt in KO muscfes, an effect which could influence 
the peak force produced prior to reaching peak tetanic force during physiological muscle 
contractions in vivo (the initial -300ms of stimulation). 
In specific gait analysis of mouse walk/trot locomotion, Clarke and Still (1999) 
established that mean stride frequency was ~3.7Hz, demonstrating that fore and hind limb 
muscles are being activated approximately every 270ms. Given that each stride includes 
both agonist and antagonist muscle activity, each muscle would be activated for a brief 
period of time during these types of locomotion (likely much shorter than 270ms). These 
findings provides clear evidence that mouse muscles are not simulated for sufficient 
duration in vivo to reach maximal force. Furthermore, potentiation of high frequency 
force production for short duration contractions by augmented +dP/dt could be possible 
and quite meaningful for in vivo contractile performance. Specifically, myosin RLC 
phosphorylation could provide fatigue resistant benefits if peak force production during 
brief contractions could be maintained throughout fatigue by augmented +dP/dt. 
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Despite the almost two-fold difference in absolute +dP/dt values between WT and 
KO muscles at each time point, the depressive effect of fatigue on this contractile 
parameter was equal between groups as both exhibited a similar relative depression in 
+dP/dt at I-minute and 5-minute (Figure 21). This observation demonstrates that the 
ablation of skMLCK does not significantly influence the fatigue mechanisms responsible 
for the decline in +dP/dt during fatigue. In addition, the relative difference in absolute 
+dP/dt between WT and KO muscles did not differ noticeably during fatigue in spite of a 
significant increase in myosin RLC phosphate content found in WT muscles between 
Rest and I-minute. This result suggests that the beneficial effect of myosin RLC 
phosphorylation on +dP/dt may have been present at rest or very early during fatigue; and 
furthermore, that there may be no extra benefit to myosin RLC phosphorylation above 
some submaximallevel of myosin RLC phosphate content. 
Shortening-induced deactivation (SID) was assessed indirectly by comparison of 
the +dP/dt before and after the 20% Lo length step of each slack test. The rationale for 
this analysis was to investigate whether myosin RLC phosphorylation influences the 
rapid deactivation of the thin filament during active shortening. SID was treated as a 
mechanism distinct from muscle relaxation and from those factors that influence 
crossbridge detachment during crossbridge cycling. As explained previously, maximal 
crossbridge cycling is rate-limited by the rate of crossbridge detachment, which is in turn 
restricted by factors that influence the affinity for ATP hydrolysis and the release of 
ADP. SID is therefore a unique mechanism whereby rapid shortening of muscle length 
imposed during an isometric contraction causes reduces the activation level of the thin 
filament. In the present analysis, SID was quantified as the ratio of +dP/dt before and 
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after a 20% Lo length step. The ability of the muscle to redevelop force after rapid 
shortening therefore represented an indirect measure of the activation level of the thin 
filament where an observed depression in +dP/dt was assumed to be a product of SID. 
The novel finding that SID was attenuated in skMLCK KO muscles reveals that 
myosin RLC phosphorylation may act as an important modulator of thin filament 
activation during active shortening. Specifically, it appears that muscles deactivate to a 
greater extent during active shortening in the presence of elevated myosin RLC 
phosphate content. Initially, this observation seemed to provide evidence that myosin 
RLC phosphate exacerbates fatigue by making WT muscles more susceptible to SID. It is 
possible that greater SID would transiently impede subsequent contractile performance, 
inducing a greater energy cost for activation in WT muscles to compensate for this 
mechanism. However, the absolute +dP/dt measured following the rapid length step in 
WT muscles was the same or greater than in KO muscles. This observation demonstrates 
that although WT muscles exhibited relatively more SID than KO muscles, this did not 
occur at a substantial cost to contractile performance. The question that emerges from this 
analysis is, does more SID benefit the contractile performance of WT muscles during 
fatigue? The observation that myosin RLC phosphorylation enhances rapid deactivation 
during active shortening without diminishing absolute rate of force development below 
skMLCK KO muscles suggests that this mechanism could be important for rapid cycles 
of muscle activation. For example, a muscle with elevated myosin RLC phosphate 
content could improve the repetitive rapid attachment and detachment of myosin 
crossbridges. However, the present results only represent a theoretical model for analysis, 
as the mechanism( s) that actually limit maximal stride frequency of muscles in vivo have 
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not been well established. Despite this, myosin RLC phosphorylation could represent an 
important mechanism that facilitates both the rapid activation and deactivation of the 
contractile apparatus during rapid cycles of muscle contraction. It is unclear, however, 
how the presence of elevated myosin RLC phosphorylation would exacerbate SID and 
what affect this would have on the physiological function of skeletal muscles in vivo. 
6.3.0 Myosin RLC Phosphorylation 
As hypothesized, myosin RLC phosphate content was depressed in skMLCK 
knockout mice and did not increase in response to repetitive high frequency stimulation. 
The low level of phosphorylation measured in KO muscles (0.07 P-skRLC/Total-skRLC) 
cannot be accounted for in the present study, as total skMLCK was not measured. An 
additional kinase could have be present to phosphorylate the RLC, however, this enzyme 
would not likely be contraction activated, as myosin RLC phosphate content did not 
increase in KO muscles during fatigue. WT muscles exhibited increased myosin RLC 
phosphate content during the first minute of stimulation and remained similarly elevated 
throughout the five minutes of stimulation (p<O.OOI). Although not significant, the small 
decrease in RLC phosphate content from I-minute to 5-minutes suggests that 
myoplasmic [Ca2+] may have been progressively decreasing as muscular fatigue 
progressed, decreasing the activity of skMLCK. 
The myosin RLC phosphate content of WT muscles at rest (0.39 P-skRLC/Total-
skRLC) was higher than previously reported values of ~0.15 and ~O.l (Zhi et aI, 2005; 
Vandenboom et al. 1993). A probable explanation for this result is that the handling of 
the mouse EDL muscle immediately prior to rapid freezing may mechanically induce a 
small release of Ca2+ in the muscle, thus activating skMLCK. This possibility highlights 
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the importance of adopting a freezing method that minimizes the physical manipulation 
of a muscle before it is frozen. A second possibility for the elevated resting myosin RLC 
phosphate content is that preceding contractile activity had elevated myosin RLC 
phosphorylation. However, muscles frozen for myosin RLC phosphorylation analysis 
were always sUbjected to a 20-minute period of quiescence before freezing and twitch 
pacing was employed during these 20-minute periods to ensure the full decline in twitch 
force potentiation to baseline values, so it appears to be unlikely that myosin RLC 
phosphorylation could persist in the absence of potentiation. 
The present results confirm the efficacy of skMLCK gene ablation for the purpose 
of studying the mechanism of myosin RLC phosphorylation. Given the substantial 
difference in myosin RLC phosphorylation between WT and KO muscles at all time 
points, it is likely that the observed differences in contractile function were largely 
associated with this primary intervention. 
6.4.0 Relative Change in Metabolic Accumulation Throughout Fatigue 
The present results provide evidence that the metabolic requirement of skeletal 
muscles with elevated myosin RLC phosphate content may not be constant during 
fatigue; and moreover, that a higher metabolic cost may be evident in skMLCK knockout 
muscles during more prolonged periods of fatigue. However, statistical investigation 
demonstrated that mean metabolite concentrations did not differ between WT and KO 
muscles. This finding may be a product of the study design itself, however, and might 
well have obscured an important trend. 
87 
, 
N N 
(J'I 
0 0 
(J'I 
0 
';I. ';I. ';I. 
~ 
~ 
Q 
r; 
I 
» 
StJ 
II 
• • ~ N (J'I 
';I. ';I. 
~ 
~ 
Q 
'l 
):> 
StJ 
II 
% Change from Rest 
... ... ... 
(J'I -..j 0 N (J'I 0 (J'I 0 (J'I 8 0 0 0 0 
';I. ';I. ';I. ';I. ';I. 
% Change from 1 Minute 
... N 
-..j 8 (J'I 0 
';I. ';I. 
I 
:::s 
i 
I 
I 
i 
a 
en 
f 
c 
i 
Figure 26. The relative change in concentration of each metabolite from rest to 1-minute (Left) 
and from 1-minute to 5-minutes (Right). The initial effect offatigue was similar in both WT and KO 
muscles, however, this pattern was not recapitulated in the remaining 4-minutes of stimulation. In 
most cases, WT and KO muscles exhibited opposite changes in metabolite concentrations. KO 
muscles displayed changes that suggested further progression of fatigue, whereas WT muscles 
actually demonstrated relative improvements in most measures (increased PCr, decreased Cr, 
La-, Pi). These results were not evaluated statistically as each was simply calculated as the 
dividend between mean metabolite concentrations at each time point and expressed as a 
percentage. 
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The data presented in Figure 26 demonstrate that WT and KO muscles did not 
perform similarly in terms of the metabolic cost of contraction during the second, more 
prolonged portion of the fatigue protocol. In both groups, the majority of the absolute 
change in metabolite concentrations occurred during the ftrst minute of fatigue. 
Discounting the variable muscle lactate values, the metabolic response of WT and KO 
muscles during the ftrst minute of stimulation was reasonably similar. During this period 
of time, peak force output (Po) and shortening velocity (Vo) were similar in WT and KO 
muscles. Twitch force potentiation and rate of force development were signiftcantly 
greater in WT muscles throughout this interval, an observation in agreement with the 
concurrent increase in myosin RLC phosphate content. In comparison, the remaining 4-
minutes of the fatigue protocol demonstrated similar trends in terms of contractile 
performance (Po, Vo, +dPldt, SID) despite a marked variation in the metabolic cost of 
contraction in WT and KO muscles. 
A reasonable supposition would be that WT muscles may incur a larger metabolic 
cost during the initial stages of fatigue due to the increased A TP cost of myosin RLC 
phosphorylation; and once myosin RLC phosphate content is elevated, that the metabolic 
cost of contraction may decrease to some degree. This hypothesis cannot be elucidated 
with the current data but is in agreement with the findings of Abbate et al. (200 I) that the 
metabolic cost of contraction was greater than the increase in mechanical work output in 
potentiated rat fast skeletal muscle during 10 intermittent contractions at 60Hz. The 
protocol utilized in the aforementioned study was considerably shorter than the current 
experiments, lasting approximately I-minute. Had Abbate et al. (2001) extended their 
protocol to 5-minutes, their ftndings may have more closely resembled the present 
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results. In addition, Crow and Kushmerick (1982b) demonstrated that elevated myosin 
light chain phosphorylation was associated with a decrease in the total splitting of high-
energy phosphates during an isometric contraction, and suggested that this observation is 
likely the product of reduced myosin ATPase activity. The current experiments did not 
produce a statistically significant difference in metabolite concentrations, therefore the 
hypothesis that a decrease in the energy cost for contraction mitigated by elevated myosin 
RLC phosphorylation cannot be satisfactorily answered. 
The absence of statistically significant results in the present metabolic data was 
likely the product of small sample sizes (n=2-S) and relatively high within group 
variability. These sources of inconsistency were attributed to human error within the 
extraction procedure and during each metabolic assay itself. An inherent difficulty with 
the current metabolic analysis is the task of quantifying very low concentrations of 
metabolites in such small muscle samples (:s Img dry wt). In future studies, muscle 
samples of ~ 1.Smg dry wt are likely necessary to produce accurate and consistent data. 
90 
VII. CONCLUSIONS & SIGNIFICANCE 
7.1.0 Primary Findings 
• Myosin RLC phosphorylation was virtually nonexistent in skMLCK knockout 
mouse EDL muscles and did not increase significantly with repetitive stimulation. 
• Myosin RLC phosphate content rapidly increased in WT muscles with repetitive 
stimulation to ~0.63 P-skRLC/Total-skRLC at I-minute, and remained similarly 
elevated throughout the fatigue protocol to 5-minutes. 
• Muscle twitch force was protected in WT muscles for the first 35-seconds of the 
fatigue protocol, whereas Po was depressed up to 40%. 
• skMLCK KO muscles did not exhibit PTP following a conditioning stimulus, 
although a small degree of twitch force potentiation (~13%) was observed during 
the first 20-seconds of fatigue. 
• The presence (or absence) of myosin RLC phosphorylation did not influence 
maximal force production (Po) or maximal unloaded shortening velocity (Vo). 
• Rate of force development (+dP/dt) was almost two-fold greater in WT compared 
to KO muscles at all stages of fatigue. The relative degradation of +dP/dt was 
similar in WT and KO muscles. 
• Shortening-induced deactivation (SID) was exacerbated in WT muscles at all 
stages of fatigue. 
• WT and skMLCK KO muscles exhibited statistically similar concentrations of 
muscle metabolites prior to, during, and following the 5-minute fatigue protocol. 
• A noteworthy trend in energy utilization occurred, however, as WT muscles 
demonstrated a noticeably larger energy cost during the first minute of stimulation 
(greater PCr depletion, pronounced Cr and La- accumulation). 
• WT muscles may be more efficient metabolically when myoSIn RLC 
phosphorylation is high, as seen during the remaining 4-minutes of stimulation 
(increased PCr, decreased Cr and La} 
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7.2.0 Significance a/Findings 
The purpose of the present study was to explore whether myosm RLC 
phosphorylation resists fatigue by maintaining the performance response of the 
contractile apparatus during repeated activation. The inhibition of myosin RLC 
phosphorylation in skMLCK KO muscles provided an important experimental control to 
study both contractile and metabolic measures in the absence of the modulatory 
mechanism of interest. The interpretation of the present study is that the absence of 
myosin RLC phosphorylation does not meaningfully modify the progressive loss of 
maximal force and shortening velocity that characterizes muscle fatigue. However, the 
potentiation of low frequency force production in WT muscles is a clear indication that 
myosin RLC phosphorylation may preserve contractile function at low or moderate 
intensities during repetitive stimulation. The stimulation protocol used in the present 
study is likely more severe than almost all types of activity in humans (peak force was 
depressed ~60% in the first minute). Therefore, the role of low frequency force 
potentiation and myosin RLC phosphorylation in resisting fatigue during less rigorous 
patterns of activation may be more important and longer lasting than reported here. 
The current results provide substantial evidence that myosm RLC 
phosphorylation may delay fatigue in vivo, where different patterns of stimulation 
intensity and duration during physiological movements could make the most of the 
various contractile benefits associated with myosin RLC phosphorylation. Of these 
benefits, an augmented rate of force development appears to be the most likely to 
maintain contractile function at all stages of muscle fatigue. The finding that both rate of 
force development and deactivation are attenuated in skMLCK KO muscles also suggests 
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that myosm RLC phosphorylation may also play a modulatory role in the rapid 
application and removal of force-producing actin-myosin interactions during repetitive 
cycles of muscle activation. 
The observation that myosin RLC phosphorylation may impose an additional 
ATP demand while concurrently improving Ca2+ sensitivity and mechanical function 
demonstrates that this mechanism could play an important role in muscle metabolism. It 
is possible that myosin RLC phosphorylation offers a contractile benefit to muscles early 
in fatigue by maintaining low frequency forces, but imposes a greater ATP demand until 
myosin RLC phosphate content is elevated maximally. At this point, the mechanical 
benefits are likely still present (increased +dP/dt) but the energy cost of contraction may 
actually decrease during the subsequent period of repetitive stimulation. It is presently 
unclear if elevated myosin RLC phosphorylation significantly decreases the metabolic 
economy of working muscles, and furthermore, whether this may occur due to an 
alteration in the affinity for ATP hydrolysis to spare ATP turnover. 
The in vitro preparation does not contain natural feedback systems that may be 
important to physiological function in vivo. Of these, the most important is the theory that 
as myosin RLC phosphorylation increases the contractile performance of a muscle (Ca2+ 
sensitivity), the activation requirement (i.e. motor unit firing rates) may diminish 
accordingly to ensure a steady mechanical output (see Appendix 5 for schematic). This 
mechanism would have the potential to decrease metabolic demand and ATP turnover by 
reducing the Ca2+ handling requirements in the muscle (Ca2+ release and active reuptake), 
and more importantly, may help spare the strength of activation required for a given 
contractile output in the muscle. 
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7.3.0 Future Research & Considerations 
Investigation of the following research questions would directly extend the scope 
of the present findings, and contribute to the continued production of new knowledge in 
the fields of muscle and exercise physiology. 
• To what extent does myosin RLC phosphorylation contribute to low-frequency 
force potentiation during repetitive contractions, and is there a calcium-handling 
component to this phenomenon? 
• Although myosin RLC phosphorylation may not influence maximal unloaded 
shortening velocity, is shortening velocity at various submaximal forces 
significantly influenced? 
• Does myosin RLC phosphorylation improve high-frequency force production 
during brief contractions (<i:300ms) by enhancing the initial rate of force 
development? Does this contractile benefit prevent fatigue or just delay its effect? 
• Does myosin RLC phosphorylation enhance SID across different contraction 
types or during concentric/eccentric work cycles? Are either of these mechanisms 
present during active lengthening, is there lengthening-induced deactivation? 
• What is the metabolic cost of contraction in the phosphorylated state and is there 
a transitional period of increased metabolic demand when myosin RLC phosphate 
content increases rapidly? 
• What is the relationship between force output and central nervous muscle 
activation? Can the body sense an improvement in Ca2+ sensitivity and does this 
feedforward to alter or pace motor unit firing rates infast twitch skeletal muscle? 
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7.4.0 Assumptions 
• The procedures involved in the storage, homogenization and analysis of muscle tissue 
will accurately reflect the true metabolic conditions sampled at the time of freezing. 
• Electrical field stimulation of EDL muscles in vitro similarly reflects how muscles are 
activated in vivo. 
• The Tyrode solution provides an exercising muscle with similar ions concentrations 
found in vivo. 
• The decrement in rate of force development after active shortening is a function of 
shortening-induced deactivation. 
• That statistical conclusions extracted from the present experiments truly represent the 
population being sampled. 
7.5.0 Limitations 
• The observations and conclusions of the current study are principally limited to 
exploring the function of fast twitch mammalian skeletal muscle in carefully 
controlled in vitro conditions. Mouse EDL muscle is relatively homogeneous in 
nature, and extrapolating the physiological role of myosin RLC phosphorylation to 
larger, heterogeneous muscles may be problematic. 
• In vivo muscle activity is not well approximated by isometric contractions, as 
physiological contractile performance is highly dependent on muscle length and 
changes thereof. 
• The present in vitro experiments were conducted at sub-physiological temperatures 
(25°C). The findings presented previously may not accurately reflect the true effect of 
myosin RLC phosphorylation on muscle function at 3r C. 
• The quantification of unloaded shortening velocity (Vo) represents only the maximal 
capacity of the fastest fibres to redevelop force. The physiological range of maximal 
shortening at zero load (V max) in vivo is typically an underestimation of Vo (Claflin & 
Faulkner, 1985). The differences between Vo and V max therefore represents the 
shortening capacity of the slower fibres found in whole muscles with heterogeneous 
fibre types. 
95 
REFERENCES 
Abbate, F., Van Der Velden, 1., Stienen, G. 1., & De Haan, A. (2001). Post-tetanic 
potentiation increases energy cost to a higher extent than work in rat fast skeletal 
muscle. Journal of Muscle Research and Cell Motility, 22(8), 703-710. 
Allen, D. G. (2004). Skeletal muscle function: Role of ionic changes in fatigue, damage 
and disease. Clinical and Experimental Pharmacology & Physiology, 31(8),485-
493. 
Allen, D. G., Lamb, G. D., & Westerblad, H. (2008a). Impaired calcium release during 
fatigue. Journal of Applied Physiology (Bethesda, Md.: 1985), 104(1),296-305. 
Allen, D. G., Lamb, G. D., & Westerblad, H. (2008b). Skeletal muscle fatigue: Cellular 
mechanisms. Physiological Reviews, 88(1),287-332. 
Allen, D. G., Lannergren, 1., & Westerblad, H. (1995). Muscle cell function during 
prolonged activity: Cellular mechanisms of fatigue. Experimental Physiology, 
80(4),497-527. 
Allen, D. G., & Westerblad, H. (2001). Role of phosphate and calcium stores in muscle 
fatigue. The Journal of Physiology, 536(Pt 3),657-665. 
Altringham, J. D., & Johnston, I. A. (1985). Effects of phosphate on the contractile 
properties of fast and slow muscle fibres from an antarctic fish. The Journal of 
Physiology, 368,491-500. 
Aydin, 1., Korhonen, T., Tavi, P., Allen, D. G., Westerblad, H., & Bruton, J. D. (2007). 
Activation of ca(2+ )-dependent protein kinase II during repeated contractions in 
single muscle fibres from mouse is dependent on the frequency of sarcoplasmic 
reticulum ca(2+) release. Acta Physiologica (Oxford, England), 191(2), 131-137. 
Baldwin, K. M., Klinkerfuss, G. H., Terjung, R. L., Mole, P. A., & Holloszy, 1. O. 
(1972). Respiratory capacity of white, red, and intermediate muscle: Adaptative 
response to exercise. The American Journal of Physiology, 222(2),373-378. 
Balnave, C. D., & Allen, D. G. (1996). The effect of muscle length on intracellular 
calcium and force in single fibres from mouse skeletal muscle. The Journal of 
Physiology, 492 ( Pt 3)(Pt 3), 705-713. 
Barclay, C.1. (2005). Modelling diffusive 02 supply to isolated preparations of 
mammalian skeletal and cardiac muscle. Journal of Muscle Research and Cell 
Motility. (26), 225-235. 
Baudry, S., & Duchateau, 1. (2007). Postactivation potentiation in a human muscle: 
Effect on the load-velocity relation of tetanic and voluntary shortening 
96 
contractions. Journal of Applied Physiology (Bethesda, Md.: 1985), 103(4), 1318-
1325. 
Bottinelli, R. (2001). Functional heterogeneity of mammalian single muscle fibres: Do 
myosin isoforms tell the whole story? Pflugers Archiv : European Journal of 
Physiology, 443(1),6-17. 
Bowditch, H. P. (1871). Uber die eigenthumlichkeiten der reizbarkeit welche die 
muskelfasern des herzens zeigen. Ber Sachs Ges Wiss, 23,652-689. 
Brenner, B. (1988). Effect of Ca2+ on cross-bridge turnover kinetics in skinned single 
rabbit psoas fibres: implications for regulation of muscle contraction. Proc. Natl. 
Acad. Sci. USA 85, 3265-3269 
Brown, L. T., & Tuttle, W. W. (1926). The phenomenon of treppe in intact human 
skeletal muscle. Am Physiol Soc., 77, 483-490. 
Bruton, 1 D., Lannergren, 1, & Westerblad, H. (1998). Mechanisms underlying the slow 
recovery of force after fatigue: Importance of intracellular calcium. Acta 
Physiologica Scandinavica, 162(3),285-293. 
Chase, P. B., & Kushmerick, M. J. (1995). Effect of physiological ADP concentrations 
on contraction of single skinned fibres from rabbit fast and slow muscles. The 
American Journal of Physiology, 268(2 Pt 1), C480-9. 
Claflin, D. R., & Faulkner, J. A. (1985). Shortening velocity extrapolated to zero load and 
unloaded shortening velocity of whole rat skeletal muscle. The Journal of 
Physiology, 359,357-363. 
Clarke, K. A., & Still, 1 (1999). Gait Analysis in the Mouse. Physiology and Behavior. 
66(5). 723-729. 
Close, R., & Hoh, J. F. (1968). The after-effects of repetitive stimulation on the isometric 
twitch contraction of rat fast skeletal muscle. The Journal of Physiology, 197(2), 
461-477. 
Cooke, R. (1997). Actomyosin interaction in striated muscle. Physiological Reviews, 
77(3),671-697. 
Cooke, R. (2007). Modulation of the actomyosin interaction during fatigue of skeletal 
muscle. Muscle & Nerve, 36(6),756-777. 
Cooke, R., & Pate, E. (1985). The effects of ADP and phosphate on the contraction of 
muscle fibres. Biophysical Journal, 48(5), 789-798. 
97 
Crow, M. T., & Kushmerick, M.l (1982a). Chemical Energetics of Slow- and Fast-
Twitch Muscles of the Mouse. Journal of General Physiology. (79). 147-166. 
Crow, M. T., & Kushmerick, M. 1 (1982b). Myosin Light Chain Phosphorylation Is 
Associated with a Decrease in the Energy Cost for Contraction in Fast Twitch 
Mouse Muscle. The Journal of Biological Chemistry, 257(5). 2121-2124. 
Debold, E. P., Dave, H., & Fitts, R. H. (2004). Fibre type and temperature dependence of 
inorganic phosphate: Implications for fatigue. American Journal of 
Physiology. Cell Physiology, 287(3), C673-81. 
Dudley, G. A., Tullson, P. C., & Terjung, R.L. (1987). Influence of Mitochondrial 
Content on the Sensitivity of Respiratory Control. The Journal of Biological 
Chemistry. 269(19),9101-9114. 
Edman, K A. (1975). Mechanical deactivation induced by active shortening in isolated 
muscle fibres of the frog. The Journal of Physiology, 246(1),255-275. 
Edman, K A. (1979). The velocity of unloaded shortening and its relation to sarcomere 
length and isometric force in vertebrate muscle fibres. The Journal of Physiology, 
291, 143-159. 
Edman, K A. (1996). Fatigue vs. Shortening-induced deactivation in striated muscle. 
Acta Physiologica Scandinavica, 156 (3), 183-192. 
Fabiato, A., & Fabiato, F. (1978). Effects of pH on the myofilaments and the 
sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. The 
Journal of Physiology, 276,233-255. 
Fitts, R. H. (2008). The cross-bridge cycle and skeletal muscle fatigue. Journal of 
Applied Physiology (Bethesda, Md.: 1985), 104(2),551-558. 
Fowles, 1 R., & Green, H. J. (2003). Coexistence of potentiation and low-frequency 
fatigue during voluntary exercise in human skeletal muscle. Canadian Journal of 
Physiology and Pharmacology, 81(12), 1092-1100. 
Franks-Skiba, K, Lardelli, R., Goh, G., & Cooke, R. (2007). Myosin light chain 
phosphorylation inhibits muscle fibre shortening velocity in the presence of 
vanadate. American Journal of Physiology. Regulatory, Integrative and 
Comparative Physiology, 292(4), RI603-12. 
Godt, R. E., & Nosek, T. M. (1989). Changes of intracellular milieu with fatigue or 
hypoxia depress contraction of skinned rabbit skeletal and cardiac muscle. The 
Journal of Physiology, 412,155-180. 
98 
Gordon, A. M., Homsher, E., & Regnier, M. (2000). Regulation of contraction in striated 
muscle. Physiological Reviews, 80(2), 853-924. 
Gordon, A. M., Regnier, M., & Homsher, E. (2001). Skeletal and cardiac muscle 
contractile activation: Tropomyosin "rocks and rolls". News in Physiological 
Sciences: An International Journal of Physiology Produced Jointly by the 
International Union of Physiological Sciences and the American Physiological 
Society, 16, 49-55. 
Grange, R. W., Cory, C. R., Vandenboom, R., & Houston, M. E. (1995). Myosin 
phosphorylation augments force-displacement and force-velocity relationships of 
mouse fast muscle. The American Journal of Physiology, 269(3 Pt 1), C713-24. 
Grange, R. W., Vandenboom, R., & Houston, M. E. (1993). Physiological significance of 
myosin phosphorylation in skeletal muscle. Canadian Journal of Applied 
Physiology = Revue Canadienne De Physiologie Appliquee, 18(3), 229-242. 
Grange, R. W., Vandenboom, R., Xeni, J., & Houston, M. E. (1998). Potentiation of in 
vitro concentric work in mouse fast muscle. Journal of Applied Physiology 
(Bethesda, Md: 1985), 84(1),236-243. 
Gulick, A. M., & Rayment, 1. (1997). Structural studies on myosin II: Communication 
between distant protein domains. BioEssays : News and Reviews in Molecular, 
Cellular and Developmental Biology, 19(7),561-569. 
Hanson, J., & Huxley, H. E. (1953). Structural basis of the cross-striations in muscle. 
Nature, 172(4377),530-532. 
Hodgson, M., Docherty, D., & Robbins, D. (2005). Post-activation potentiation: 
Underlying physiology and implications for motor performance. Sports Medicine 
(Auckland, NZ.), 35(7), 585-595. 
Houston, M.E. (2006). Biochemistry Primer for Exercise Science. Windsor, ON: Human 
Kinetics. 
Huxley, H., & Hanson, J. (1954). Changes in the cross-striations of muscle during 
contraction and stretch and their structural interpretation. Nature, 173(4412),973-
976. 
Huxley, H. E. (1953). Electron microscope studies of the organisation of the filaments in 
striated muscle. Biochimica Et Biophysica Acta, 12(3),387-394. 
Huxley, H. E. (1957). The double array of filaments in cross-striated muscle. The Journal 
of Biophysical and Biochemical Cytology, 3(5),631-648. 
99 
Huxley, H. E. (1969). The mechanism of muscular contraction. Science (New York, NY), 
164(886), 1356-1365. 
Jiang, Y, & Julian, F. 1. (1999). Effects of ramp shortening during linear phase of 
relaxation on [Ca2+]i in intact skeletal muscle fibres. The American Journal of 
Physiology, 276(1 Pt 1), C152-60. 
Kabbara, A. A., & Allen, D. G. (1999). The role of calcium stores in fatigue of isolated 
single muscle fibres from the cane toad. The Journal of Physiology, 519 Pt 1, 
169-176. 
Karatzaferi, C., Franks-Skiba, K., & Cooke, R. (2008). Inhibition of shortening velocity 
of skinned skeletal muscle fibres in conditions that mimic fatigue. American 
Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 
294(3), R948-55. 
Klug, G. A., Botterman, B. R., & Stull, 1. T. (1982). The effect of low frequency 
stimulation on myosin light chain phosphorylation in skeletal muscle. The Journal 
of Biological Chemistry, 257(9),4688-4690. 
Krarup, C. (1981). Temperature dependence of enhancement and diminution of tension 
evoked by staircase and by tetanus in rat muscle. The Journal of Physiology, 311, 
373-387. 
Kushmerick, M. 1., Moerland, T. S., & Wiseman, R. W. (1993). Two classes of 
mammalian skeletal muscle fibres distinguished by metabolite content. Advances 
in Experimental Medicine and Biology, 332, 749-60; discussion 760-1. 
Kushmerick, M. J., Moerland, T. S., & Wiseman, R. W. (1992). Mammalian skeletal 
muscle fibres distinguished by contents of phosphocreatine, ATP, and pi. 
Proceedings of the National Academy of Sciences of the United States of America, 
89(16),7521-7525. 
Lee, F. S. (1906). The cause of treppe. Am Physiol Soc., 18,267-282. 
Manning, D. R., & Stull, 1. T. (1979). Myosin light chain phosphorylation and 
phosphorylase A activity in rat extensor digitorum longus muscle. Biochemical 
and Biophysical Research Communications, 90( 1), 164-170. 
Manning, D. R., & Stull, 1. T. (1982). Myosin light chain phosphorylation-
dephosphorylation in mammalian skeletal muscle. The American Journal of 
Physiology, 242(3), C234-41. 
McKillop, D. F., & Geeves, M. A. (1993). Regulation of the interaction between actin 
and myosin subfragment 1: Evidence for three states of the thin filament. 
Biophysical Journal, 65(2),693-701. 
100 
Metzger, 1. M. (1996). Effects of phosphate and ADP on shortening velocity during 
maximal and submaximal calcium activation of the thin filament in skeletal 
muscle fibres. Biophysical Journal, 70(1),409-417. 
Morgan, M., Perry, S. V., & Ottaway, 1. (1976). Myosin light-chain phosphatase. The 
Biochemical Journal, 157(3),687-697. 
Persechini, A., Stull, 1. T., & Cooke, R. (1985). The effect of myosin phosphorylation on 
the contractile properties of skinned rabbit skeletal muscle fibres. The Journal of 
Biological Chemistry, 260(13), 7951-7954. 
Pette, D., & Staron, R. S. (2000). Myosin isoforms, muscle fibre types, and transitions. 
Microscopy Research and Technique, 50(6),500-509. 
Posterino, G. S., & Dunn, S. L. (2008). Comparison of the effects of inorganic phosphate 
on caffeine-induced Ca2+ release in fast- and slow-twitch mammalian skeletal 
muscle. American Journal of Physiology. Cell Physiology, 294(1), C97-105. 
Rassier, D. E., & Macintosh, B. R. (2000). Coexistence of potentiation and fatigue in 
skeletal muscle. Brazilian Journal of Medical and Biological Research = Revista 
Brasileira De Pesquisas Medicas e Biologicas / Sociedade Brasileira De Biofisica 
.. .[Et AI.}, 33(5),499-508. 
Rassier, D. E., & MacIntosh, B. R. (2000). Length dependence of staircase potentiation: 
Interactions with caffeine and dantrolene sodium. Canadian Journal of 
Physiology and Pharmacology, 78(4),350-357. 
Rassier, D. E., & MacIntosh, B. R. (2002). Sarcomere length-dependence of activity-
dependent twitch potentiation in mouse skeletal muscle. BMC Physiology, 2, 19. 
Rassier, D. E., Tubman, L. A., & MacIntosh, B. R. (1997). Length-dependent 
potentiation and myosin light chain phosphorylation in rat gastrocnemius muscle. 
The American Journal of Physiology, 273(1 Pt 1), CI98-204. 
Rassier, D. E., Tubman, L. A., & MacIntosh, B. R. (1998). Caffeine and length 
dependence of staircase potentiation in skeletal muscle. Canadian Journal of 
Physiology and Pharmacology, 76(10-11),975-982. 
Rayment, 1., Holden, H. M., Whittaker, M., Yohn, C. B., Lorenz, M., Holmes, K. C., et 
al. (1993). Structure of the actin-myosin complex and its implications for muscle 
contraction. Science (New York, NY.), 261(5117),58-65. 
Rijkelijkhuizen,1. M., de Ruiter, C. 1., Huijing, P. A., & de Haan, A. (2005). Low-
frequency fatigue, post-tetanic potentiation and their interaction at different 
muscle lengths following eccentric exercise. The Journal of Experimental 
Biology, 208(Pt 1), 55-63. 
101 
Ritz-Gold, C. 1., Cooke, R., Blumenthal, D. K., & Stull, J. T. (1980). Light chain 
phosphorylation alters the conformation of skeletal muscle myosin. Biochemical 
and Biophysical Research Communications, 93(1),209-214. 
Ryder,1. W., Lau, K. S., Kamm, K. E., & Stull, 1. T. (2007). Enhanced skeletal muscle 
contraction with myosin light chain phosphorylation by a calmodulin-sensing 
kinase. The Journal o/Biological Chemistry, 282(28),20447-20454. 
Sahlin. K., Harris, R. c., Nylind, B., & Hultman, E. (1976). Lactate Content and pH in 
Muscle Samples Obtained after Dynamic Exercise. European Journal 0/ 
Physiology. 367, 143-149. 
Sale, D. G. (2002). Postactivation potentiation: Role in human performance. Exercise and 
Sport Sciences Reviews, 30(3), 138-143. 
Spriet, L.L. (1989). ATP utilization and provision in fast-twitch skeletal muscle during 
tetanic contractions. American Journal o/Physiology, 257, E595-605. 
Stein, R. B., Gordon, T., & Shriver, J. (1982). Temperature dependence of mammalian 
muscle contractions and ATPase activities. Biophysical Journal, 40(2),97-107. 
Szczesna, D., Zhao, 1., Jones, M., Zhi, G., Stull, J., & Potter, J. D. (2002). 
Phosphorylation of the regulatory light chains of myosin affects Ca2+ sensitivity 
of skeletal muscle contraction. Journal 0/ Applied Physiology (Bethesda, Md.: 
1985), 92(4), 1661-1670. 
Vandenboom, R., Grange, R. W., & Houston, M. E. (1993). Threshold for force 
potentiation associated with skeletal myosin phosphorylation. The American 
Journalo/Physiology, 265(6 Pt 1), CI456-62. 
Vandenboom, R., Grange, R. W., & Houston, M. E. (1995). Myosin phosphorylation 
enhances rate of force development in fast-twitch skeletal muscle. The American 
Journal 0/ Physiology, 268(3 Pt 1), C596-603. 
Vandenboom, R., & Houston, M. E. (1996). Phqsphorylation of myosin and twitch 
potentiation in fatigued skeletal muscle. Canadian Journal of Physiology and 
Pharmacology, 74(12), 1315-1321. 
Vandenboom, R., Xeni, 1., Bestic, N. M., & Houston, M. E. (1997). Increased force 
development rates of fatigued mouse skeletal muscle are graded to myosin light 
chain phosphate content. The American Journal 0/ Physiology, 272(6 Pt 2), 
RI980-4. 
Vandenboom, R., Claflin, D. R., & Julian, F. J. (1998). Effects of rapid shortening on rate 
of force regeneration and myoplasmic [Ca2+] in intact frog skeletal muscle fibres. 
The Journal o/Physiology, 511 (Pt 1)(Pt 1),171-180. 
102 
Vandenboom, R., Hannon, J. D., & Sieck, G. C. (2002). Isotonic force modulates force 
redevelopment rate of intact frog muscle fibres: Evidence for cross-bridge 
induced thin filament activation. The Journal of Physiology, 543(Pt 2), 555-566. 
Vandenboom, R. (2004). The myofibrillar complex and fatigue: A review. Canadian 
Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquee, 
29(3), 330-356. 
Westerblad, H., & Allen, D. G. (1991). Changes ofmyoplasmic calcium concentration 
during fatigue in single mouse muscle fibres. The Journal of General Physiology, 
98(3),615-635. 
Westerblad, H., Allen, D. G., Bruton, J. D., Andrade, F. H., & Lannergren, J. (1998). 
Mechanisms underlying the reduction of isometric force in skeletal muscle 
fatigue. Acta Physiologica Scandinavica, 162(3), 253-260. 
Westerblad, H., Allen, D. G., & Lannergren, J. (2002). Muscle fatigue: Lactic acid or 
inorganic phosphate the major cause? News in Physiological Sciences: An 
International Journal of Physiology Produced Jointly by the International Union 
of Physiological Sciences and the American Physiological Society, 17, 17-21. 
Yang, Z., Stull, J. T., Levine, R. J., & Sweeney, H. L. (1998). Changes in interfilament 
spacing mimic the effects of myosin regulatory light chain phosphorylation in 
rabbit psoas fibres. Journal of Structural Biology, 122(1-2), 139-148. 
Zhi, G., Ryder, J. W., Huang, J., Ding, P., Chen, Y., Zhao, Y., et al. (2005). Myosin light 
chain kinase and myosin phosphorylation effect frequency-dependent potentiation 
of skeletal muscle contraction. Proceedings of the National Academy of Sciences 
of the United States of America, 1 02(48), 17519-17524. 
103 
APPENDIX 1: Force & Length Tracings 
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Figure 27. Potentiation of muscle twitch force following the standard conditioning stimulus. Traces 
A & B are from WT and KO muscles at O.9Lo. Traces C & D were collected from WT and KO 
muscles at 1.0Lo. 
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Figure 28. Force and length tracings sampled from a Slack Test. (Top) Length steps are induced 
during a fully fused tetanic contraction. (Middle) Tetanic force production prior to and following the 
rapid length step. (Bottom) Force redevelopment tracings after a length step. Slack time 
increases linearly with increasing step size from 10% La to 20% La. This relationship was used to 
calculate unloaded shortening velocity (Va). 
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APPENDIX 2: Methods for Metabolic Assays & Fluorometry 
Metabolite Extraction 
Often the preparation of the tissue is the most critical. In the case of metabolite assays, the most 
hazardous period is usually the period between the moment the O2 supply is cut off and the moment the 
enzyme activity is finally stopped. Rapid freezing is essential. Therefore, most metabolite analysis is 
performed on extracts prepared from frozen tissue. Most metabolites are assayed in protein-free extracts 
prepared with perchloric acid (HCI04). HCI04 is preferred because most of it can be easily removed by 
precipitation as a potassium salt. All of the following analyses are performed on freeze-dried tissue. Not 
only does it circumvent the problem of changing water contents in tissue, but also because the tissue is 
much easier to work with. Enzymes are rendered inactive in a water-free environment, and will remain so 
until water is re-added. Therefore, the weighing of the samples can be performed at room temperature and 
the tissue can be dissected free of connective tissues and blood. 
Procedure 
1. Freeze dry tissue (overnight to ensure all water is removed) 
2. Store with dry rite in freezer until powdering 
3. Tease out connective tissue and powder 
4. Place in pre-weighed microcentrifuge tube and weigh (0.6 - 1.0 mg) 
5. Place tubes in an ice bucket (make sure tubes remain cold) 
6. Add 240 ilL of pre-cooled 0.5 M PCA 
7. Extract for 10 minutes, vortexing several times (ensure all tissue is in contact with PCA) 
8. Centrifuge for lO minutes at 15 000 G (spinning helps remove some of the enzymes that can influence 
concentration) 
9. Remove 216 ilL and place in freezer (-20°C) for 10 min 
10. To the frozen supernatant add 54 ilL of2.2 M KHC03 and vortex until liquid (addition ofKHC03 to a 
frozen supernatant prevents foaming over) 
11. Centrifuge 10 min 4°C at 15 OOOG. Remove supernate to assay metabolites. 
* Note: Dilution factors were varied for individual muscle size. PCA, Supernatent, KHC03 were altered 
accordingly. For samples <0.6mg [lOO/85/21.25J, 0.6-1.5mg (2001180/45), > 1.5mg (2401126/54). 
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Muscle Adenosine Triphosphate (ATP) and Phosphocreatine (Per) Assay 
CREATINE KINASE 
P-CREA TINE + ADP----------------------------------------7 CREATINE + A TP 
HEXOKINASE 
ATP + GLUCOSE-----------------------------------------7 ADP + GLUCOSE-6-P 
G-6-P-DH 
GLUCOSE-6-P + NADP--------------------------------7 GLUCANOLACTONE + NADPH 
Reagent STOCK FINAL VOLUME VOLUME VOLUME 
CONC. CONC. 2SML SOML lOOML 
1. Tris Buffer (on 
shelf) 0.1 M 50mM 1.25 ml 2.5 m! 5.00 ml 
(pH 8.1) 
stored in fridge 
2. MgClz (on shelf) LOOM 1.0mM 25.00 ilL 50.00 ilL 100.00 ilL 
fresh (.2033g/ml) 
3.D.T.T. 0.5M 0.5mM 25.00 ilL 50.00 ilL 100.00 ilL 
(found in -20) 
aliquots -80 
4. Glucose 100.OmM 100.0 11M 25.00 ilL 50.00 ilL 100.00 ilL 
(on shelf) 
aliquots (-80) 
S.NADP 50.0mM 50.0 11M 25.00 ilL 50.00 ilL 100.00 ilL 
(found in -20) 
aliquots (-80) 
6. G-6-P-DH 2660 Vlml 0.02 Vlml 1.00 ilL 2.00 ilL 4.00 ilL 
(found in fridge) 
Sigma (G-5760) 
8. ADP (found Solid 
in -20) 
Sigma (A-2754) 
9. Creatine 
Kinase 324 U/mg 
(found in -20) 
Sigma (C-3755) 
Note: Mix reagents 1-5 together. Bring to volume with distilled water and adjust to pH 8.1. Then add 
reagent 6. Mix by inversion with enzymes. 
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Procedure for Assay (Note: Run everything in triplicate) 
1. Fill three wells with a blank (10.00 ilL dH20 per well) 
2. a. Vortex each concentration mixture before pipetting 
b. Fill the next five wells with 1O.001lL of varying concentrations of ATP 
standard (0.05 mM, O.l mM, 0.2 mM, 0.3 mM, 0.4 mM) 
3. a. Vortex each concentration mixture before pipetting 
b. Fill the next five wells with 10.00 ilL of varying concentrations of the 
PCr standard. (O.l mM, 0.2 mM, 0.4 mM, 0.8 mM, l.2 mM) 
4. a. Vortex each sample before pipetting 
b. Add 10.00 ilL of sample to the appropriately wells 
5. Add 185 ilL of reagent to each well 
6. Incubate for 25 minutes. 
7. Read the plate at sensitivity of 80 (excitation setting 340, emission setting 460) (base line reading) 
Part 2. 
Preparation: Mix 2.5 ilL of Hexokinase with 1ml oftris buffer. Mix by inversion. 
1. Add 6 ilL of dilute Hexokinase to all of the wells 
2. Place in the dark for 80 minutes 
3. Read the plate at sensitivity of 80 (excitation setting 340, emission setting 460) 
(R2-R1 = reflects ATP in extract) 
Part 3. 
Preparation: Mix ~ l.5 mg of phosphocreatine kinase and 5 mg of ADP into 5 ml of tris buffer. Mix 
by inversion. 
1. Add 6 ilL of dilute CPKI ADP mixture to all of the wells 
2. Place in the dark for 120 minutes 
3. Read the plate at sensitivity of 80 (excitation setting 340, emission setting 460) 
(R3-R2= reflects PCr in extract) 
ATP (Sigma A-7699) Standard Curve 
-Make fresh 5.51 mg into 5 mL dH20 
Conc(mM) 
0.05 
0.1 
0.2 
0.3 
0.4 
Stock (ilL) 
25 
50 
100 
150 
200 
Phosphocreatine (Sigma P-7936) Standard Curve 
-Stored in 7.6 mM aliquots in the -80°C 
-To make 7.6 mM stock: mix 96.94mg PCr into 50mL dH20 
Conc(mM) 
0.076 
0.152 
0.304 
0.608 
0.912 
C4H8N30SPNa • 4.4 mol H20-mOrl substance 
Therefore its effective weight is 334.3 gemor1 
Stock (ilL) 
10 
20 
40 
80 
120 
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975 
950 
900 
850 
800 
990 
980 
960 
920 
880 
Muscle Creatine (Cr) Assay 
CREA TINE KINASE 
CREA TINE + A TP----------------------------------------7 P-CREA TINE + ADP 
PYRUVATE KINASE 
ADP + P-PYRUV ATE-----------------------------------------7 ATP + PYRUVATE 
LDH 
PYRUVATE + NADH--------------------------------7 LACTATE + NAD 
Reagent STOCK FINAL VOLUME VOLUME VOLUME 
CONC CONC 25ml 50 ml 100ml 
..................................... --.... __ ... ........................................ _ ......... -....... -
- ... --.---. ... "_ ........ --........ - . ..................................................................... --_ ....... 
1. Imidazole 1.00M 50mM 1.25 ml 2.5 ml 5.00 ml 
(on shelf) 
(pH 8.1) 
stored in aliquots ( -80) 
2. MgCh (on shelf) l.OOM 5.0mM 125.00 ilL 250.00 ilL 500.00 ilL 
make fresh (.2033g/ml) 
3. KCl (on shelf) 1.00M 30.00mM 0.75 ml 1.5 ml 3.00 ml 
make fresh (.148gl2ml) 
4. PEP (found in -20) 10.OmM 25.0 11M 60.00 ilL 120.00 ilL 240.00 ilL 
stored in aliquots (-80) 
5. A TP (found in -20) SOLID 200 11M 3mg 6mg 12mg 
make fresh 
6.NADH 15mM 45 11M 75.00 ilL 150.00 ilL 300.00 ilL 
(found in -20) 
Sigma (N-8129) 
make fresh 10.5 mg/ml 
7.LDH 5264 U/ml 0.24 U/ml 1.10 ilL 2.3 ilL 4.6 ilL 
(found in fridge) 
Sigma (L-5132) 
8. Pyruvate Kinase 1252 U/ml 0.75 U/ml 15.00 ilL 30.00 ilL 60.00 ilL 
(found in fridge) 
Sigma (P-1506) 
9. Creatine Kinase 324 Ulmg 3.6 Ulml 
(found in -20) 
Sigma (C-3755) 
Note: Mix reagents 1-6 together. Bring to volume with distilled water and adjust to pH 7.5. Then add 
reagents 7 & 8. Mix by inversion when enzymes added. 
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Before beginning to pipette the samples you must test the fluorescence of the buffer (might have to 
change gain) 
Procedure for Assay 
Prepare Standards 
Part 1. 
1. Fill three wells with a blank (10.00 ilL dH20 per well) 
2. a. Vortex each concentration mixture before pipetting 
b. Fill the next five wells with 10.001lL of varying concentrations of Cr standard (O.lmM, 0.2 mM, 0.4 
mM, 0.8 mM, 1.2 mM) 
3. a. Vortex each sample before pipetting 
b. Add 10.00 ilL of sample to the appropriately wells 
4. Add 185 ilL of buffer to each well 
5. Incubate for 30 minutes 
6. Read the plate at a sensitivity of 100 (excitation setting 340, emission setting 460) (base line reading) 
Part 2. 
Preparation: Mix 1.0 mg of Creatine Kinase with 2.6 ml of buffer. Mix by inversion. 
1. Add 6 ilL of dilute Creatine Kinase to all of the wells 
2. Place in the dark for 55 minutes 
3. Read the plate (excitation setting 340, emission setting 460) 
Note: Everything analyzed in triplicate 
Creatine (Sigma C0780-50g) Standard Curve 
-Stored in 10 mM aliquots in the -80°C 
-To make 10 mM stock: 131.1 mg into 100 ml dH20 
Cone (mM) Stock (uL) 
0.1 10 
0.2 20 
0.4 40 
0.8 80 
1.2 120 
110 
dH20 (umol·L-1) 
990 
980 
960 
920 
880 
Muscle Lactate Assay 
LDH 
Lactate + NAD+ ----------------------------------------7 Pyruvate + NADH + H+ 
PYRUVATE + Hydrazine ----------------------------------------7 Pyruvate Hydrazone 
Reagent STOCK FINAL VOLUME VOLUME 
CONC CONC 25ml 50mt 
-~.-----------
1. Hydrazine l.OOM 100.OmM 2.5 ml 5.00 ml 
stored in fridge 
make fresh bi-weekly 
2. Glycine LOOM 100.OmM 2.5 ml 5.00 ml 
stored in fridge 
make fresh bi-weekly 
3.NAD+ 100.0mM 0.5mM 125 ilL 250 ilL 
(found in -20) 
stored in aliquots ( -80) 
4.LDH 5264 Ulml 8 U/ml See Procedure 
(found in fridge) 
Sigma (L-5l32) 
Note: Mix reagents 1-3 together. Bring to volume with distilled H20 and adjust to pH 10. 
Preparation of Dilute Enzyme (dependant on LDH) 
Sigma L-5132 
-Add 60 ilL ofLDH to 1.0 ml of reagent. Mix by inversion. (For 50 ml do 
120 ilL of reagent). 
Sigma L-2500 
-17.25 ilL ifusing L-2500, LDH 
Procedure for Assay 
Prepare Standards 
Part I. 
1. Fill three wells with a blank (10.00 ilL dH20 per well) 
2. a. Vortex each concentration mixture before pipetting 
VOLUME 
100ml 
10.00 ml 
10.00 ilL 
500.00 ilL 
b. Fill the next five wells with 1O.001lL of varying concentrations of lactate standard (0.025 mM, 
0.05 mM, 0.1 mM, 0.2 mM, 0.8 mM) 
3. a. Vortex each sample before pipetting 
b. Add 10.00 ilL of sample to the appropriately wells 
4. Add 185 ilL of buffer to each well 
5. Incubate for 15 minutes 
6. Read the plate at a sensitivity of 100 (excitation setting 340, emission setting 460) (base line 
reading) 
III 
Part 2. 
1. Add 10 !!L of dilute LDH to all of the wells 
2. Place in the dark for 120 minutes 
3. Read the plate at a sensitivity of 1 00 (excitation setting 340, emission setting 460) 
Note: Run everything in triplicate 
Lactate Standard Curve 
-Pre-made lactate standard (4.44 mM) 
Conc (mM) 
0.1 
0.2 
0.4 
0.8 
1.2 
Conc (mM) 
0.025 
0.05 
0.1 
0.2 
0.8 
1.2 
Stock (uL) 
23 
45 
90 
180 
270 
Stock (uL) 
5.6 
11.25 
22.5 
45 
180 
270 
*Preferred Curve ~ 1.2mM not always necessary 
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977 
955 
910 
820 
730 
994 
988 
978 
955 
820 
730 
APPENDIX 3: Calculation of ADPfree & Inorganic Phosphate Concentrations 
Calculation orfPt] & Estimating Resting [PJ 
[Pi] = delta PCr (Rest - Exercise) + resting Pi 
Resting inorganic phosphate concentrations were estimated according to the specific 
fibre-type composition of mouse EDL muscles reported previously (Crow & 
Kushmerick, 1982a; Kushmerick et al. 1992; Kushmerick et al. 1993). 
Mouse EDL contains ~ 
.63 type lIB 
.36 typeIIX 
.01 type I 
Resting Pi measured in each fibre type ~ 
Type !IA, lIB: 0.8 mMlkg.dry W(l 
Type I, !IX: 6.0 mMlkg.dry W(l 
Resting [Pi] was therefore calculated according to the following relationship: 
[PJ = (63*0.8)+(36*6.0)+(01 *6.0) 
= 2.27 mMlkg.dry W(I 
Calculating muscle pH & Estimating [Pyruvate! 
Muscle pH was calculated from the relationship ofLa+ & Pyruvate (Sahlin. et al. 1976). 
pH = -0.00413 x (La- + Pyr) + 7.06 
Muscle [Pyruvate] was not directly measured but estimated according to the results of 
Sahlin et al. (1976), where [Pyruvate] equals between 0.5-4% of muscle lactate. This 
range was ~0.4 - 0.7mM. Muscle pyruvate content was therefore calculated as 2.25% of 
muscle lactate concentration. 
pH= -log[F] 
[F] = lQ1l-pH) M 
Calculating ADP ~ 
ADPfree was calculated using the known equilibrium constant Keq for the creatine kinase 
reaction, as previously described by Dudley et al. (1987). 
Keq = 1.66x 106 JlM= [ATP] [Cr] I [H+] [PCr] [ADP] 
[ADP] = [A TP]*[Cr] 11.66 x 106 x [PCr] x [H+] 
To calculate ADP in Ilmollkg.dry wrl, concentrations of metabolites must be entered as 
mmol/kg.dry wrl. H+ must be entered in mmol. 
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APPENDIX 4: Metabolic Changes During Skeletal Muscle Fatigue 
Table 6. The following table of values represents the approximate change in concentration of 
specific muscle metabolites and pH in skeletal muscle during fatigue. Where available, values 
were selected from studies of intact, mammalian skeletal muscle. All other sources were 
compiled from studies of human, murine, and/or amphibian skeletal muscle preparations. The 
actual metabolite concentration measured in working skeletal muscle is largely determined by the 
species from which the sample was obtained and the manner in which the sample was analyzed; 
although the intensity and duration of muscle activation are important considerations for the 
evaluation of 'normal' metabolite values within a given fatigue protocol. Values are presented as 
mol/kg wet weight. 
Metabolite Rest Fatigued 
ATP 5-6mM 1,4 2-4mM 1.4 
A DPfree 20IJM 1 250IJM 1 
A MPfree - OIJM 2 2IJM 2 
IMP -OmM 3 5mM 3 
Pi 2mM 1 25mM 1 
PCr 20mM 4 :::;5mM 3 
Cr 15mM 4 30mM 4 
Lactate 1-2mM 3,4 30-40mM 3,4 
pH (-log[H+J) 7.0 1 
1 as reviewed by Vandenboom (2004) 
2 as reviewed by Houston (2006) 
3 as reviewed by Allen, Lamb & Westerblad (2008) 
4 Spriet (1989) 
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6.21 
APPENDIX 5: Myosin RLC Phosphorylation & Muscle Activation In Vivo 
Figure 29. Afferent feedback (mechanical & metabolic) from working muscles may be used as 
important physiological information that regulates pacing strategies and peripheral motor unit 
firing frequencies in vivo. In this model, the body is subconsciously aware of muscle performance 
and the intensity of activation required to maintain a given steady-state activity. This information 
is processed by higher cortical structures (sensory & motor cortex, basal ganglia, cerebellum), 
and is applied to the coordination of complex movements and activities. It is assumed that the 
body will intrinsically alter complex physiological processes to operate in the most economical 
way possible during voluntary exercise. Applying the mechanism of myosin RLC phosphorylation 
to this model suggests that a given increase in contractile performance (increased Ca2+ 
sensitivity) for the same activation requirement (motor unit firing rate) may allow the body to 
decrease motor unit firing rates while maintaining some steady pace or muscle performance. A) 
The brain. The control of human movement requires complex processing that takes afferent 
(sensory) information into account when producing efferent signals to effector organs (i.e. working 
muscles). 8) The spinal cord is the conduit that transfers all afferent and efferent information 
throughout the body. C) The peripheral nervous system is the local system of nerves that 
transfers sensory information from to the spinal cord, and additionally, carries the descending 
signals that activate muscles at the neuromuscular junction. D) The effector organ (i.e. muscle) is 
activated by the peripheral motor neuron and contains structures that measure and produce 
feedback information that is sent back to the brain (i.e. Golgi tendon organs, muscle spindles). 
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